{"id":69505,"date":"2026-02-15T00:30:24","date_gmt":"2026-02-14T15:30:24","guid":{"rendered":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/"},"modified":"2026-02-24T11:09:38","modified_gmt":"2026-02-24T02:09:38","slug":"metabolic-dysfunction-associated-steatohepatitis-market-imarc","status":"publish","type":"post","link":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/","title":{"rendered":"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp\" alt=\"Market Report Image\" style=\"max-width:100%;\"><\/p>\n<p>1 \u00a0 \u5e8f\u6587<br \/>\n2 \u00a0 \u7bc4\u56f2\u3068\u65b9\u6cd5\u8ad6<br \/>\n\u00a0 \u00a0 2.1 \u00a0 \u00a0\u7814\u7a76\u306e\u76ee\u7684<br \/>\n\u00a0 \u00a0 2.2 \u00a0 \u00a0\u95a2\u4fc2\u8005<br \/>\n\u00a0 \u00a0 2.3 \u00a0 \u00a0\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 2.3.1 \u00a0 \u00a0\u4e00\u6b21\u60c5\u5831\u6e90<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 2.3.2 \u00a0 \u00a0\u4e8c\u6b21\u60c5\u5831\u6e90<br \/>\n\u00a0 \u00a0 2.4 \u00a0 \u00a0\u5e02\u5834\u63a8\u5b9a<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 2.4.1 \u00a0 \u00a0\u30dc\u30c8\u30e0\u30a2\u30c3\u30d7\u30a2\u30d7\u30ed\u30fc\u30c1<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 2.4.2 \u00a0 \u00a0\u30c8\u30c3\u30d7\u30c0\u30a6\u30f3\u30a2\u30d7\u30ed\u30fc\u30c1<br \/>\n\u00a0 \u00a0 2.5 \u00a0 \u00a0\u4e88\u6e2c\u65b9\u6cd5\u8ad6<br \/>\n3 \u00a0 \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<br \/>\n4 \u00a0 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e &#8211; \u5e8f\u8ad6<br \/>\n\u00a0 \u00a0 4.1 \u6982\u8981<br \/>\n\u00a0 \u00a0 4.2 \u898f\u5236\u30d7\u30ed\u30bb\u30b9<br \/>\n\u00a0 \u00a0 4.3 \u75ab\u5b66 (2019-2024) \u304a\u3088\u3073\u4e88\u6e2c (2025-2035)<br \/>\n\u00a0 \u00a0 4.4 \u5e02\u5834\u6982\u8981 (2019-2024) \u304a\u3088\u3073\u4e88\u6e2c (2025-2035)<br \/>\n\u00a0 \u00a0 4.5 \u7af6\u5408\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9<br \/>\n5 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e &#8211; \u75be\u60a3\u6982\u8981<br \/>\n\u00a0 \u00a0 5.1 \u00a0 \u00a0\u5e8f\u8ad6<br \/>\n\u00a0 \u00a0 5.2 \u00a0 \u00a0\u75c7\u72b6\u3068\u8a3a\u65ad<br \/>\n\u00a0 \u00a0 5.3 \u00a0 \u00a0\u75c5\u614b\u751f\u7406<br \/>\n\u00a0 \u00a0 5.4 \u00a0 \u00a0\u539f\u56e0\u3068\u5371\u967a\u56e0\u5b50<br \/>\n\u00a0 \u00a0 5.5 \u00a0 \u00a0\u6cbb\u7642<br \/>\n6 \u60a3\u8005\u30b8\u30e3\u30fc\u30cb\u30fc<br \/>\n7 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e &#8211; \u75ab\u5b66\u3068\u60a3\u8005\u4eba\u53e3<br \/>\n\u00a0 \u00a0 7.1 \u00a0 \u00a0\u75ab\u5b66 &#8211; \u4e3b\u8981\u306a\u6d1e\u5bdf\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 7.2 \u00a0 \u00a0\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa &#8211; \u4e3b\u89817\u5e02\u5834<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 7.2.1 \u75ab\u5b66\u30b7\u30ca\u30ea\u30aa (2019-2024) \u00a0 \u00a0 \u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 7.2.2 \u75ab\u5b66\u4e88\u6e2c (2025-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.2.3 \u5e74\u9f62\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 7.2.4 \u6027\u5225\u75ab\u5b66 (2019-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0\u00a0 \u00a07.2.5 \u8a3a\u65ad\u75c7\u4f8b\u6570 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.2.6 \u60a3\u8005\u30d7\u30fc\u30eb\/\u6cbb\u7642\u75c7\u4f8b\u6570 (2019-2035)\u00a0\u00a0 \u00a0\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 7.3 \u00a0 \u00a0\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa &#8211; \u7c73\u56fd\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.3.1 \u75ab\u5b66\u30b7\u30ca\u30ea\u30aa (2019-2024)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.3.2 \u75ab\u5b66\u4e88\u6e2c (2025-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.3.3 \u5e74\u9f62\u5225\u75ab\u5b66 (2019-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 7.3.4 \u6027\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.3.5 \u8a3a\u65ad\u75c7\u4f8b\u6570 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.3.6 \u60a3\u8005\u30d7\u30fc\u30eb\/\u6cbb\u7642\u75c7\u4f8b\u6570 (2019-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 7.4 \u00a0 \u00a0\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa &#8211; \u30c9\u30a4\u30c4\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.4.1 \u75ab\u5b66\u30b7\u30ca\u30ea\u30aa (2019-2024)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.4.2 \u75ab\u5b66\u4e88\u6e2c (2025-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.4.3 \u5e74\u9f62\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0\u00a0 \u00a07.4.4 \u6027\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 \u00a07.4.5 \u8a3a\u65ad\u75c7\u4f8b\u6570 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.4.6 \u60a3\u8005\u30d7\u30fc\u30eb\/\u6cbb\u7642\u75c7\u4f8b\u6570 (2019-2035)<br \/>\n\u00a0 \u00a0 7.5 \u00a0 \u00a0\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa &#8211; \u30d5\u30e9\u30f3\u30b9\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0\u00a0\u00a0 \u00a07.5.1 \u75ab\u5b66\u30b7\u30ca\u30ea\u30aa (2019-2024)<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.5.2 \u75ab\u5b66\u4e88\u6e2c (2025-2035)<br \/>\n\u00a0 \u00a0 \u00a0\u00a0 \u00a07.5.3 \u5e74\u9f62\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0\u00a0 \u00a07.5.4 \u6027\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0 \u00a0\u00a0\u00a0 \u00a07.5.5 \u8a3a\u65ad\u75c7\u4f8b\u6570 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a07.5.6 \u60a3\u8005\u30d7\u30fc\u30eb\/\u6cbb\u7642\u75c7\u4f8b\u6570 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a07.6 \u00a0 \u00a0\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa &#8211; \u82f1\u56fd<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a07.6.1 \u75ab\u5b66\u30b7\u30ca\u30ea\u30aa (2019-2024)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a07.6.2 \u75ab\u5b66\u4e88\u6e2c (2025-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a07.6.3 \u5e74\u9f62\u5225\u75ab\u5b66 (2019<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a07.9.1 \u75ab\u5b66\u30b7\u30ca\u30ea\u30aa (2019-2024)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a07.9.2 \u75ab\u5b66\u4e88\u6e2c (2025-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a07.9.3 \u5e74\u9f62\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a07.9.4 \u6027\u5225\u75ab\u5b66 (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a07.9.5 \u8a3a\u65ad\u75c7\u4f8b (2019-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a07.9.6 \u60a3\u8005\u6570\/\u6cbb\u7642\u75c7\u4f8b (2019-2035)<br \/>\n8 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 &#8211; \u6cbb\u7642\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u3001\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3001\u533b\u7642\u6163\u884c<br \/>\n\u00a0 \u00a0 8.1 \u00a0 \u00a0\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3001\u7ba1\u7406\u3001\u6cbb\u7642<br \/>\n\u00a0 \u00a0 8.2 \u00a0 \u00a0\u6cbb\u7642\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0<br \/>\n9 \u00a0 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 &#8211; \u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba<br \/>\n10 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 &#8211; \u6cbb\u7642\u306e\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee<br \/>\n11 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 &#8211; \u5e02\u8ca9\u88fd\u54c1<br \/>\n11.1 \u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308b\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac\u306e\u5e02\u8ca9\u85ac\u30ea\u30b9\u30c8<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a011.1.1 \u30ec\u30ba\u30c7\u30a3\u30d5\u30e9 (\u30ec\u30b9\u30e1\u30c1\u30ed\u30e0) &#8211; \u30de\u30c9\u30ea\u30ac\u30eb\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a011.1.1.1 \u85ac\u5264\u6982\u8981<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 11.1.1.2 \u4f5c\u7528\u6a5f\u5e8f<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 11.1.1.3 \u81e8\u5e8a\u8a66\u9a13\u7d50\u679c<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 11.1.1.4 \u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 11.1.1.5 \u898f\u5236\u72b6\u6cc1<br \/>\n\u5b8c\u5168\u306a\u30ea\u30b9\u30c8\u306f\u6700\u7d42\u5831\u544a\u66f8\u3067\u63d0\u4f9b\u3055\u308c\u307e\u3059\u3002<br \/>\n12 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 &#8211; \u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u88fd\u54c1<br \/>\n\u00a0 \u00a0 12.1 \u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308b\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u30ea\u30b9\u30c8<br \/>\n12.1.1 \u30da\u30b4\u30b6\u30d5\u30a7\u30eb\u30df\u30f3 \u2013 89bio<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.1.1 \u85ac\u5264\u6982\u8981<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.1.2 \u4f5c\u7528\u6a5f\u5e8f<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.1.3 \u81e8\u5e8a\u8a66\u9a13\u7d50\u679c<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.1.4 \u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.1.5 \u898f\u5236\u72b6\u6cc1<br \/>\n12.1.2 \u30a8\u30d5\u30eb\u30ad\u30b7\u30d5\u30a7\u30eb\u30df\u30f3 \u2013 Akero Therapeutics<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.2.1 \u85ac\u5264\u6982\u8981<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.2.2 \u4f5c\u7528\u6a5f\u5e8f<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.2.3 \u81e8\u5e8a\u8a66\u9a13\u7d50\u679c<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.2.4 \u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.2.5 \u898f\u5236\u72b6\u6cc1<br \/>\n12.1.3 \u30df\u30ea\u30b3\u30ea\u30eb\u30e9\u30f3\u30c8 \u2013 Corcept Therapeutics<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.3.1 \u85ac\u5264\u6982\u8981<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.3.2 \u4f5c\u7528\u6a5f\u5e8f<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.3.3 \u81e8\u5e8a\u8a66\u9a13\u7d50\u679c<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.3.4 \u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.3.5 \u898f\u5236\u72b6\u6cc1<br \/>\n12.1.4 ALG-055009 \u2013 Aligos Therapeutics<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.4.1 \u85ac\u5264\u6982\u8981<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.4.2 \u4f5c\u7528\u6a5f\u5e8f<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.4.3 \u81e8\u5e8a\u8a66\u9a13\u7d50\u679c<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.4.4 \u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.4.5 \u898f\u5236\u72b6\u6cc1<br \/>\n12.1.5 ALN-HSD \u2013 Regeneron Pharmaceuticals<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.5.1 \u85ac\u5264\u6982\u8981<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.5.2 \u4f5c\u7528\u6a5f\u5e8f<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.5.3 \u81e8\u5e8a\u8a66\u9a13\u7d50\u679c<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.5.4 \u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a012.1.5.5 \u898f\u5236\u72b6\u6cc1<br \/>\n\u5b8c\u5168\u306a\u30ea\u30b9\u30c8\u306f\u6700\u7d42\u5831\u544a\u66f8\u3067\u63d0\u4f9b\u3055\u308c\u307e\u3059\u3002<br \/>\n13 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 &#8211; \u4e3b\u8981\u306a\u5e02\u8ca9\u85ac\u304a\u3088\u3073\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u306e\u5c5e\u6027\u5206\u6790<br \/>\n14 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 \u2013 \u81e8\u5e8a\u8a66\u9a13\u306e\u72b6\u6cc1<br \/>\n\u00a0 \u00a0 14.1 \u30b9\u30c6\u30fc\u30bf\u30b9\u5225\u85ac\u5264<br \/>\n\u00a0 \u00a0 14.2 \u30d5\u30a7\u30fc\u30ba\u5225\u85ac\u5264<br \/>\n\u00a0 \u00a0 14.3 \u6295\u4e0e\u7d4c\u8def\u5225\u85ac\u5264<br \/>\n\u00a0 \u00a0 14.4 \u4e3b\u8981\u306a\u898f\u5236\u30a4\u30d9\u30f3\u30c8<br \/>\n15 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u5e02\u5834\u30b7\u30ca\u30ea\u30aa<br \/>\n\u00a0 \u00a0 15.1 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa &#8211; \u4e3b\u8981\u306a\u6d1e\u5bdf<br \/>\n\u00a0 \u00a0 15.2 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa &#8211; \u4e3b\u89817\u5e02\u5834<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a015.2.1 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642 &#8211; \u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.2.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.2.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a015.2.2 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.2.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.2.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2024-2035\u5e74)<br \/>\n\u00a0 15.3 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa &#8211; \u7c73\u56fd<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 15.3.1 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.3.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a015.3.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 15.3.2 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.3.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.3.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 15.3.3 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u30a2\u30af\u30bb\u30b9\u3068\u511f\u9084\u306e\u6982\u8981<br \/>\n15.4 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa &#8211; \u30c9\u30a4\u30c4<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 \u00a015.4.1 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.4.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.4.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0\u00a0\u00a0 \u00a015.4.2 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21<br \/>\n15.4.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.4.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 15.4.3 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u30a2\u30af\u30bb\u30b9\u3068\u511f\u9084\u306e\u6982\u8981<br \/>\n\u00a0 \u00a0 15.5 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa &#8211; \u30d5\u30e9\u30f3\u30b9<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 15.5.1 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.5.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a015.5.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0\u00a0\u00a0 \u00a015.5.2 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.5.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.5.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 15.5.3 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u30a2\u30af\u30bb\u30b9\u3068\u511f\u9084\u306e\u6982\u8981<br \/>\n\u00a0 \u00a0 15.6 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa \u2013 \u82f1\u56fd<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 15.6.1 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.6.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.6.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a015.6.2 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.6.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0 \u00a0 15.6.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0\u00a0 \u00a0 15.6.3 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u30a2\u30af\u30bb\u30b9\u3068\u511f\u9084\u306e\u6982\u8981<br \/>\n15.7 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa \u2013 \u30a4\u30bf\u30ea\u30a2<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 \u00a0 15.7.1 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.7.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a015.7.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.7.2 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.7.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.7.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.7.3 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u30a2\u30af\u30bb\u30b9\u3068\u511f\u9084\u306e\u6982\u8981<br \/>\n15.8 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa &#8211; \u30b9\u30da\u30a4\u30f3<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 \u00a0 15.8.1 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.8.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0\u00a0 \u00a0\u00a0\u00a0 \u00a0 15.8.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a015.8.2 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\u6cbb\u7642\u85ac &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.8.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024\u5e74)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.8.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2025-2035\u5e74)<br \/>\n\u00a0\u00a0 \u00a0 15.8.3 \u8102\u80aa\u809d\u708e\uff08MASH\uff09\u6cbb\u7642 &#8211; \u30a2\u30af\u30bb\u30b9\u3068\u511f\u9084\u306e\u6982\u8981<br \/>\n\u00a015.9 \u00a0 \u00a0\u5e02\u5834\u30b7\u30ca\u30ea\u30aa &#8211; \u65e5\u672c\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0\u00a0\u00a0 \u00a0 15.9.1 \u8102\u80aa\u809d\u708e\uff08MASH\uff09\u6cbb\u7642 &#8211; \u5e02\u5834\u898f\u6a21\u00a0\u00a0 \u00a0<br \/>\n\u00a0\u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.9.1.1 \u5e02\u5834\u898f\u6a21 (2019-2024)\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0 \u00a0 15.9.1.2 \u5e02\u5834\u4e88\u6e2c (2025-2035)\u00a0\u00a0 \u00a0<br \/>\n\u00a0\u00a0\u00a0 \u00a0 15.9.2 \u8102\u80aa\u809d\u708e\uff08MASH\uff09\u6cbb\u7642 &#8211; \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21\u00a0<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.9.2.1 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u898f\u6a21 (2019-2024)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 15.9.2.2 \u6cbb\u7642\u6cd5\u5225\u5e02\u5834\u4e88\u6e2c (2025-2035)<br \/>\n\u00a0 \u00a0 \u00a0 \u00a0 \u00a015.9.3 \u8102\u80aa\u809d\u708e\uff08MASH\uff09\u6cbb\u7642 &#8211; \u30a2\u30af\u30bb\u30b9\u3068\u511f\u9084\u306e\u6982\u8981<br \/>\n16 \u8102\u80aa\u809d\u708e\uff08MASH\uff09\u6cbb\u7642 &#8211; \u6700\u8fd1\u306e\u51fa\u6765\u4e8b\u3068\u4e3b\u8981\u30aa\u30d4\u30cb\u30aa\u30f3\u30ea\u30fc\u30c0\u30fc\u304b\u3089\u306e\u610f\u898b<br \/>\n17 \u8102\u80aa\u809d\u708e\uff08MASH\uff09\u6cbb\u7642\u5e02\u5834 &#8211; SWOT\u5206\u6790\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a017.1 \u00a0 \u00a0\u5f37\u307f\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a017.2 \u00a0 \u00a0\u5f31\u307f\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a017.3 \u00a0 \u00a0\u6a5f\u4f1a\u00a0\u00a0 \u00a0<br \/>\n\u00a0 \u00a017.4 \u00a0 \u00a0\u8105\u5a01 \u00a0 \u00a0 \u00a0\u00a0 \u00a0<br \/>\n\u00a018 \u8102\u80aa\u809d\u708e\uff08MASH\uff09\u6cbb\u7642 &#8211; \u6226\u7565\u7684\u63d0\u8a00<br \/>\n\u00a019 \u4ed8\u9332<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u306e7\u5927\u5e02\u5834\u306f\u30012024\u5e74\u306b25\u51046,280\u4e07\u7c73\u30c9\u30eb\u306e\u898f\u6a21\u306b\u9054\u3057\u307e\u3057\u305f\u3002IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u4e88\u6e2c\u306b\u3088\u308b\u3068\u3001\u3053\u306e\u5e02\u5834\u306f2035\u5e74\u307e\u3067\u306b213\u5104230\u4e07\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3057\u30012025\u5e74\u304b\u30892035\u5e74\u306e\u9593\u306b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0921.23%\u3092\u8a18\u9332\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>MASH\u306f\u3001\u809d\u81d3\u306b\u8102\u80aa\u304c\u84c4\u7a4d\u3057\u3001\u708e\u75c7\u3092\u5f15\u304d\u8d77\u3053\u3057\u3066\u809d\u81d3\u306b\u640d\u50b7\u3092\u4e0e\u3048\u308b\u809d\u75be\u60a3\u3067\u3059\u3002\u9ad8\u8840\u7cd6\u3001\u80a5\u6e80\u3001\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u306a\u3069\u306e\u4ee3\u8b1d\u969c\u5bb3\u304c\u539f\u56e0\u3067\u767a\u751f\u3057\u3001\u591a\u91cf\u306e\u30a2\u30eb\u30b3\u30fc\u30eb\u6442\u53d6\u3092\u4f34\u308f\u306a\u3044\u8102\u80aa\u809d\u75be\u60a3\u306e\u4e00\u7a2e\u3067\u3059\u3002\u521d\u671f\u306b\u306f\u81ea\u899a\u75c7\u72b6\u304c\u306a\u3044\u3053\u3068\u3082\u591a\u304f\u3001\u75c7\u72b6\u304c\u73fe\u308c\u308b\u307e\u3067\u306b\u6570\u9031\u9593\u304b\u304b\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002\u4e2d\u7a0b\u5ea6\u306eMASH\u3067\u306f\u3001\u53f3\u4e0a\u8179\u90e8\u306e\u75db\u307f\u3001\u75b2\u52b4\u3001\u8131\u529b\u611f\u3001\u98df\u6b32\u4e0d\u632f\u3001\u539f\u56e0\u4e0d\u660e\u306e\u4f53\u91cd\u6e1b\u5c11\u304c\u898b\u3089\u308c\u307e\u3059\u3002\u9032\u884c\u3057\u305f\u30b1\u30fc\u30b9\u3067\u306f\u3001\u3042\u3056\u304c\u3067\u304d\u3084\u3059\u3044\u3001\u51fa\u8840\u3057\u3084\u3059\u3044\u3001\u809d\u4e0d\u5168\u306b\u3088\u308b\u9ec4\u75b8\u3001\u30ea\u30f3\u30d1\u7bc0\u306e\u816b\u308c\u3001\u6301\u7d9a\u7684\u306a\u304b\u3086\u307f\u3001\u809d\u81d3\u3084\u813e\u81d3\u306e\u80a5\u5927\u3001\u7cbe\u795e\u932f\u4e71\u3001\u7720\u6c17\u3001\u308d\u308c\u3064\u304c\u56de\u3089\u306a\u3044\u306a\u3069\u306e\u75c7\u72b6\u304c\u60aa\u5316\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u8a3a\u65ad\u306b\u306f\u3001\u81e8\u5e8a\u8a55\u4fa1\u3001\u5bb6\u65cf\u6b74\u3001\u8840\u6db2\u691c\u67fb\u3001\u809d\u81d3\u306e\u786c\u3055\u306e\u6e2c\u5b9a\u306b\u52a0\u3048\u3001\u8179\u90e8\u8d85\u97f3\u6ce2\u691c\u67fb\u3084CT\u30b9\u30ad\u30e3\u30f3\u306a\u3069\u306e\u753b\u50cf\u8a3a\u65ad\u304c\u7528\u3044\u3089\u308c\u3001\u809d\u81d3\u5185\u306e\u8102\u80aa\u306e\u5b58\u5728\u304c\u78ba\u8a8d\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>MASH\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3057\u3066\u3044\u308b\u306e\u306f\u3001\u80a5\u6e80\u3001\u9ad8\u8840\u5727\u3001\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u3092\u7279\u5fb4\u3068\u3057\u3001\u809d\u81d3\u3078\u306e\u8102\u80aa\u6c88\u7740\u3001\u708e\u75c7\u3001\u7622\u75d5\u5316\u3092\u5f15\u304d\u8d77\u3053\u3059\u4ee3\u8b1d\u75c7\u5019\u7fa4\u306e\u5897\u52a0\u3067\u3059\u3002\u307e\u305f\u3001\u30ec\u30e1\u30c1\u30ed\u30e0\u306a\u3069\u306eTHR-\u30d9\u30fc\u30bf\u30a2\u30b4\u30cb\u30b9\u30c8\u304c\u809d\u81d3\u306e\u8102\u8cea\u4ee3\u8b1d\u3092\u8abf\u7bc0\u3059\u308b\u3053\u3068\u3067\u75c5\u6c17\u306e\u9032\u884c\u3092\u9006\u8ee2\u3055\u305b\u308b\u52b9\u679c\u3082\u5e02\u5834\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u30d3\u30bf\u30df\u30f3E\u3001\u30aa\u30e1\u30ac3\u8102\u80aa\u9178\u3001\u30b7\u30ea\u30de\u30ea\u30f3\u306a\u3069\u306e\u6804\u990a\u88dc\u52a9\u98df\u54c1\u304c\u75c7\u72b6\u306e\u7de9\u548c\u3084\u809d\u81d3\u306e\u5065\u5eb7\u6539\u5584\u306b\u5f79\u7acb\u3064\u3068\u3055\u308c\u3001\u305d\u306e\u4f7f\u7528\u304c\u5897\u52a0\u3057\u3066\u3044\u308b\u3053\u3068\u3082\u6210\u9577\u8981\u56e0\u3067\u3059\u3002\u91cd\u5ea6\u306e\u80a5\u6e80\u306b\u5bfe\u3059\u308b\u30d0\u30a4\u30d1\u30b9\u624b\u8853\u306e\u53d7\u3051\u5165\u308c\u62e1\u5927\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3067\u3042\u308a\u3001\u3053\u306e\u624b\u8853\u306f\u30b0\u30eb\u30ab\u30b4\u30f3\u69d8\u30da\u30d7\u30c1\u30c9-1\u306a\u3069\u306e\u8178\u7ba1\u30db\u30eb\u30e2\u30f3\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u6539\u5584\u3057\u3001\u809d\u81d3\u306e\u708e\u75c7\u3092\u6291\u5236\u3057\u307e\u3059\u3002\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u306f\u3001\u5e79\u7d30\u80de\u7642\u6cd5\u3078\u306e\u610f\u8b58\u306e\u9ad8\u307e\u308a\u3082MASH\u5e02\u5834\u5168\u4f53\u306b\u52e2\u3044\u3092\u4e0e\u3048\u308b\u3067\u3057\u3087\u3046\u3002\u3053\u308c\u306f\u809d\u7d44\u7e54\u306e\u518d\u751f\u3001\u7dda\u7dad\u5316\u306e\u8efd\u6e1b\u3001\u809d\u6a5f\u80fd\u306e\u6539\u5584\u306e\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u65b0\u3057\u3044\u30ec\u30dd\u30fc\u30c8\u300cMetabolic Dysfunction-Associated Steatohepatitis Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035\u300d\u306f\u3001\u7c73\u56fd\u3001EU5\uff08\u30c9\u30a4\u30c4\u3001\u30b9\u30da\u30a4\u30f3\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\uff09\u3001\u304a\u3088\u3073\u65e5\u672c\u306eMASH\u5e02\u5834\u3092\u7db2\u7f85\u7684\u306b\u5206\u6790\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5206\u6790\u306b\u306f\u3001\u6cbb\u7642\u6cd5\u3001\u5e02\u8ca9\u85ac\u304a\u3088\u3073\u958b\u767a\u4e2d\u306e\u85ac\u5264\u3001\u500b\u5225\u7642\u6cd5\u306e\u30b7\u30a7\u30a2\u30017\u5927\u5e02\u5834\u5168\u4f53\u306e\u5e02\u5834\u5b9f\u7e3e\u3001\u4e3b\u8981\u4f01\u696d\u3068\u305d\u306e\u85ac\u5264\u306e\u5e02\u5834\u5b9f\u7e3e\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u307e\u305f\u30017\u5927\u5e02\u5834\u306b\u304a\u3051\u308b\u73fe\u5728\u304a\u3088\u3073\u5c06\u6765\u306e\u60a3\u8005\u6570\u3082\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u7c73\u56fd\u306fMASH\u306e\u60a3\u8005\u6570\u304c\u6700\u3082\u591a\u304f\u3001\u6cbb\u7642\u5e02\u5834\u3068\u3057\u3066\u3082\u6700\u5927\u3067\u3059\u3002\u3055\u3089\u306b\u3001\u73fe\u5728\u306e\u6cbb\u7642\u6cd5\/\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u3001\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\u3001\u8ab2\u984c\u3001\u6a5f\u4f1a\u3001\u511f\u9084\u30b7\u30ca\u30ea\u30aa\u3001\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u533b\u7642\u30cb\u30fc\u30ba\u306a\u3069\u3082\u5831\u544a\u66f8\u3067\u8a73\u8ff0\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u88fd\u9020\u696d\u8005\u3001\u6295\u8cc7\u5bb6\u3001\u30d3\u30b8\u30cd\u30b9\u6226\u7565\u5bb6\u3001\u7814\u7a76\u8005\u3001\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u3001\u304a\u3088\u3073MASH\u5e02\u5834\u306b\u95a2\u5fc3\u3092\u6301\u3064\u3059\u3079\u3066\u306e\u4eba\u3005\u306b\u3068\u3063\u3066\u5fc5\u8aad\u306e\u8cc7\u6599\u3067\u3059\u3002<\/p>\n<p>\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u5e02\u5834\u306f\u3001\u65b0\u305f\u306a\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u9032\u5c55\u306b\u3088\u308a\u3001\u6d3b\u767a\u306a\u52d5\u304d\u3092\u898b\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u4e3b\u306a\u9032\u5c55\u3068\u3057\u3066\u30012025\u5e741\u6708\u306b\u306fAkero Therapeutics\u793e\u304c\u3001MASH\u306b\u8d77\u56e0\u3059\u308b\u30c1\u30e3\u30a4\u30eb\u30c9\u30fb\u30d4\u30e5\u30fcA\u7d1a\u809d\u786c\u5909\uff08F4\uff09\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fefruxifermin\uff08EFX\uff09\u306e\u7b2c2b\u76f8SYMMETRY\u81e8\u5e8a\u8a66\u9a13\u306e96\u9031\u6642\u70b9\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30d9\u30fc\u30b9\u30e9\u30a4\u30f3\u306896\u9031\u76ee\u306e\u751f\u691c\u30c7\u30fc\u30bf\u304c\u3042\u308b\u60a3\u8005\uff08n=134\uff09\u306e\u3046\u3061\u300150mg\u306eEFX\u6295\u4e0e\u7fa4\uff08n=46\uff09\u3067\u306f39%\u304cMASH\u306e\u60aa\u5316\u3092\u4f34\u308f\u306a\u3044\u809d\u786c\u5909\u306e\u6539\u5584\u3092\u793a\u3057\u3001\u30d7\u30e9\u30bb\u30dc\u7fa4\uff08n=47\uff09\u306e15%\u3068\u6bd4\u8f03\u3057\u3066\u6709\u610f\u306a\u7d50\u679c\u3067\u3057\u305f\uff08p=0.009\uff09\u3002<\/p>\n<p>2024\u5e7411\u6708\u306b\u306f\u300189bio\u793e\u304c\u9032\u884c\u6027\u7dda\u7dad\u75c7\u3068MASH\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fpegozafermin\u306e\u7b2c2b\u76f8ENLIVEN\u8a66\u9a13\u306e\u65b0\u305f\u306a\u30c7\u30fc\u30bf\u89e3\u6790\u3092\u516c\u958b\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u7d50\u679c\u306f\u3001pegozafermin\u304c\u60a3\u8005\u306eFAST\u30b9\u30b3\u30a2\u3092\u6539\u5584\u3057\u305f\u3060\u3051\u3067\u306a\u304f\u3001MASH\u306e\u5bdb\u89e3\u3068\u7dda\u7dad\u75c7\u306e\u6539\u5584\u306e\u4e21\u65b9\u3092\u9054\u6210\u3057\u3001\u9032\u884c\u6027MASH\u60a3\u8005\u306e\u6709\u671b\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3067\u3042\u308b\u3053\u3068\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u30012024\u5e749\u6708\u306b\u306fAligos Therapeutics\u793e\u304c\u3001MASH\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fTHR-\u03b2\u30a2\u30b4\u30cb\u30b9\u30c8ALG-055009\u306e\u7b2c2a\u76f8HERALD\u8a66\u9a13\u3067\u6709\u671b\u306a\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002ALG-055009\u306e\u5168\u3066\u306e\u6295\u4e0e\u7fa4\u306b\u304a\u3044\u3066\u300112\u9031\u76ee\u304b\u3089MRI-\u30d7\u30ed\u30c8\u30f3\u5bc6\u5ea6\u8102\u80aa\u5206\u753b\uff08MRI-PDFF\uff09\u3067\u6e2c\u5b9a\u3055\u308c\u305f\u809d\u8102\u80aa\u306e\u6709\u610f\u306a\u6e1b\u5c11\u304c\u78ba\u8a8d\u3055\u308c\u3001\u4e3b\u8981\u76ee\u6a19\u3092\u9054\u6210\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>MASH\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306f\u3001\u3044\u304f\u3064\u304b\u306e\u4e3b\u8981\u306a\u85ac\u5264\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n\u300cRezdiffra\u300d\u306f\u3001\u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u809d\u7dda\u7dad\u75c7\u3092\u4f34\u3046MASH\u60a3\u8005\u306b\u5bfe\u3057\u3001\u98df\u4e8b\u3068\u904b\u52d5\u7642\u6cd5\u3068\u4f75\u7528\u3057\u3066\u6295\u4e0e\u3055\u308c\u307e\u3059\u3002\u4e3b\u306b\u809d\u81d3\u306e\u7d30\u80de\u3067\u767a\u73fe\u3059\u308b\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u30d9\u30fc\u30bf\u306e\u90e8\u5206\u4f5c\u52d5\u85ac\u3068\u3057\u3066\u6a5f\u80fd\u3057\u3001\u8102\u8cea\u4ee3\u8b1d\u306b\u95a2\u308f\u308b\u907a\u4f1d\u5b50\u3092\u8abf\u7bc0\u3059\u308b\u3053\u3068\u3067\u3001\u809d\u5185\u30c8\u30ea\u30b0\u30ea\u30bb\u30ea\u30c9\u3092\u6e1b\u5c11\u3055\u305b\u3001\u809d\u8102\u80aa\u3092\u4f4e\u6e1b\u3057\u3001\u809d\u81d3\u306e\u5065\u5eb7\u3092\u5897\u9032\u3057\u307e\u3059\u3002<\/p>\n<p>89bio\u793e\u304c\u958b\u767a\u3057\u305f\u300cPegozafermin\u300d\u306f\u3001\u5929\u7136\u306b\u5b58\u5728\u3059\u308b\u7dda\u7dad\u82bd\u7d30\u80de\u5897\u6b96\u56e0\u5b5021\uff08FGF21\uff09\u3092\u6a21\u5023\u3057\u3066\u4f5c\u7528\u3057\u3001\u4e3b\u306b\u809d\u81d3\u3092\u6a19\u7684\u3068\u3057\u307e\u3059\u3002\u3053\u306e\u85ac\u5264\u306f\u6297\u708e\u75c7\u4f5c\u7528\u3068\u6297\u7dda\u7dad\u5316\u4f5c\u7528\u3092\u6301\u3061\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u9ad8\u3081\u3001\u30c8\u30ea\u30b0\u30ea\u30bb\u30ea\u30c9\u30ec\u30d9\u30eb\u3092\u4f4e\u4e0b\u3055\u305b\u307e\u3059\u3002\u809d\u7dda\u7dad\u75c7\u3068\u708e\u75c7\u306e\u4e3b\u8981\u306a\u8981\u56e0\u3092\u6a19\u7684\u3068\u3059\u308b\u3053\u3068\u3067MASH\u306e\u6cbb\u7642\u3092\u52a9\u3051\u3001\u30a2\u30c7\u30a3\u30dd\u30cd\u30af\u30c1\u30f3\u5408\u6210\u306e\u4fc3\u9032\u3084\u809d\u81d3\u306b\u304a\u3051\u308b\u904a\u96e2\u8102\u80aa\u9178\u7ba1\u7406\u306e\u5f37\u5316\u3068\u3044\u3063\u305f\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u542b\u307f\u307e\u3059\u3002<\/p>\n<p>Akero Therapeutics\u793e\u304c\u958b\u767a\u3057\u305f\u300cEfruxifermin\u300d\u3082\u3001\u4ee3\u8b1d\u30db\u30eb\u30e2\u30f3\u3067\u3042\u308b\u7dda\u7dad\u82bd\u7d30\u80de\u5897\u6b96\u56e0\u5b5021\uff08FGF21\uff09\u306e\u5929\u7136\u306e\u6d3b\u6027\u3092\u6a21\u5023\u3057\u307e\u3059\u3002\u809d\u81d3\u304a\u3088\u3073\u8102\u80aa\u7d44\u7e54\u306e\u7d30\u80de\u306b\u3042\u308b\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3057\u3066\u4ee3\u8b1d\u7d4c\u8def\u3092\u5909\u5316\u3055\u305b\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3001\u708e\u75c7\u3001\u7dda\u7dad\u5316\u3068\u3044\u3063\u305fMASH\u306e\u7279\u5fb4\u3092\u6e1b\u5c11\u3055\u305b\u307e\u3059\u3002\u672c\u8cea\u7684\u306bFGF21\u30a2\u30b4\u30cb\u30b9\u30c8\u3068\u3057\u3066\u6a5f\u80fd\u3057\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3068\u8102\u8cea\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6539\u5584\u3057\u306a\u304c\u3089\u3001\u5168\u8eab\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3067MASH\u75be\u60a3\u9032\u884c\u306e\u591a\u304f\u306e\u8981\u7d20\u306b\u5bfe\u51e6\u3057\u307e\u3059\u3002<\/p>\n<p>Corcept Therapeutics\u793e\u304c\u958b\u767a\u3057\u305f\u300cMiricorilant\u300d\u306f\u3001\u9078\u629e\u7684\u30b0\u30eb\u30b3\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u30e2\u30b8\u30e5\u30ec\u30fc\u30bf\u30fc\uff08SGRM\uff09\u304a\u3088\u3073\u30df\u30cd\u30e9\u30eb\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\u3068\u3057\u3066\u4f5c\u7528\u3057\u307e\u3059\u3002\u4e3b\u306b\u809d\u81d3\u306e\u3053\u308c\u3089\u306e\u53d7\u5bb9\u4f53\u3068\u306e\u76f8\u4e92\u4f5c\u7528\u3092\u901a\u3058\u3066\u3001\u809d\u8102\u80aa\u306e\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3001\u4ee3\u8b1d\u6307\u6a19\u3092\u6539\u5584\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u3001MASH\u306e\u6f5c\u5728\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u306a\u308a\u5f97\u307e\u3059\u3002<\/p>\n<p>\u300cALG-055009\u300d\u306f\u3001MASH\u306e\u7ba1\u7406\u3092\u76ee\u7684\u3068\u3057\u305f\u30af\u30e9\u30b9\u6700\u9ad8\u306e\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u30d9\u30fc\u30bf\u4f5c\u52d5\u85ac\u3067\u3059\u3002\u8102\u8cea\u4ee3\u8b1d\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u3067\u3042\u308bAPOC3\u306e\u963b\u5bb3\u3092\u901a\u3058\u3066\u305d\u306e\u52b9\u679c\u3092\u767a\u63ee\u3057\u307e\u3059\u3002ALG-055009\u306b\u3088\u308bAPOC3\u306e\u963b\u5bb3\u306f\u3001\u6b63\u5e38\u306a\u8102\u8cea\u4ee3\u8b1d\u3092\u56de\u5fa9\u3055\u305b\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3066\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u9ad8\u3081\u3001\u305d\u308c\u306b\u3088\u308a\u708e\u75c7\u3068\u7dda\u7dad\u5316\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u307e\u3059\u3002<\/p>\n<p>\u672c\u7814\u7a76\u306e\u5bfe\u8c61\u671f\u9593\u306f\u3001\u57fa\u6e96\u5e74\u304c2024\u5e74\u3001\u904e\u53bb\u671f\u9593\u304c2019\u5e74\u304b\u30892024\u5e74\u3001\u5e02\u5834\u4e88\u6e2c\u671f\u9593\u304c2025\u5e74\u304b\u30892035\u5e74\u3067\u3059\u3002\u5bfe\u8c61\u56fd\u306f\u7c73\u56fd\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u65e5\u672c\u304c\u542b\u307e\u308c\u3001\u5404\u56fd\u306b\u304a\u3051\u308b\u904e\u53bb\u3001\u73fe\u5728\u3001\u304a\u3088\u3073\u4e88\u6e2c\u5206\u6790\u304c\u30ab\u30d0\u30fc\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u904e\u53bb\u3001\u73fe\u5728\u3001\u305d\u3057\u3066\u5c06\u6765\u306b\u308f\u305f\u308b\u5e02\u5834\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u3001\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa\u3001\u304a\u3088\u3073\u69d8\u3005\u306a\u6cbb\u7642\u30ab\u30c6\u30b4\u30ea\u30fc\u306e\u52d5\u5411\u3092\u8a73\u7d30\u306b\u8a55\u4fa1\u3057\u307e\u3059\u3002<\/p>\n<p>\u75ab\u5b66\u306e\u5074\u9762\u3067\u306f\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308bMASH\u306e\u6709\u75c5\u8005\u6570\uff082019-2035\u5e74\uff09\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u60a3\u8005\u30d7\u30fc\u30eb\u3092\u3001\u5e74\u9f62\u5225\u3001\u6027\u5225\u3092\u542b\u3080\u8a73\u7d30\u306a\u30c7\u30fc\u30bf\u3067\u5206\u6790\u3057\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u30012019\u5e74\u304b\u30892035\u5e74\u307e\u3067\u306e\u6709\u75c5\u8005\u6570\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u305d\u3057\u30662019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u60a3\u8005\u30d7\u30fc\u30eb\u898f\u6a21\u30682025\u5e74\u304b\u30892035\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u60a3\u8005\u30d7\u30fc\u30eb\u304c\u63d0\u793a\u3055\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u75ab\u5b66\u7684\u50be\u5411\u3092\u63a8\u9032\u3059\u308b\u4e3b\u8981\u56e0\u3068\u60a3\u8005\u6570\u306e\u6210\u9577\u7387\u3082\u4e88\u6e2c\u3057\u3001MASH\u306e\u75be\u60a3\u8ca0\u62c5\u306b\u95a2\u3059\u308b\u6df1\u3044\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306b\u3064\u3044\u3066\u306f\u3001MASH\u5e02\u5834\u5168\u4f53\u306e\u904e\u53bb\u3001\u73fe\u5728\u3001\u5c06\u6765\u306e\u52d5\u5411\u3092\u8a55\u4fa1\u3057\u3001\u69d8\u3005\u306a\u6cbb\u7642\u30ab\u30c6\u30b4\u30ea\u30fc\u306e\u5e02\u5834\u30b7\u30a7\u30a2\uff082024\u5e74\u304a\u3088\u30732035\u5e74\u4e88\u6e2c\uff09\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308b\u5404\u56fd\u5225\u306eMASH\u5e02\u5834\u898f\u6a21\uff082024\u5e74\u304a\u3088\u30732035\u5e74\u4e88\u6e2c\uff09\u3001\u5e02\u5834\u306e\u6210\u9577\u7387\u3001\u305d\u3057\u3066\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3092\u660e\u3089\u304b\u306b\u3057\u307e\u3059\u3002\u69d8\u3005\u306a\u85ac\u5264\u306e\u58f2\u4e0a\u9ad8\u3084\u511f\u9084\u30b7\u30ca\u30ea\u30aa\u3082\u8a73\u7d30\u306b\u5206\u6790\u5bfe\u8c61\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u6cbb\u7642\u85ac\u306e\u72b6\u6cc1\u3068\u3057\u3066\u3001\u73fe\u5728\u5e02\u8ca9\u3055\u308c\u3066\u3044\u308b\u85ac\u5264\u3068\u5f8c\u671f\u6bb5\u968e\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u5264\u306e\u4e21\u65b9\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u3001\u5404\u85ac\u5264\u306e\u6982\u8981\u3001\u4f5c\u7528\u6a5f\u5e8f\u3001\u898f\u5236\u72b6\u6cc1\u3001\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3001\u85ac\u5264\u306e\u666e\u53ca\u72b6\u6cc1\u3001\u5e02\u5834\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u3001Madrigal Pharmaceuticals\u306eRezdiffra\uff08Resmetirom\uff09\u300189bio\u306ePegozafermin\u3001Akero Therapeutics\u306eEfruxifermin\u3001Corcept Therapeutics\u306eMiricorilant\u3001Aligos Therapeutics\u306eALG-055009\u3001Regeneron Pharmaceuticals\u306eALN-HSD\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u3053\u308c\u3089\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3082\u8a55\u4fa1\u3055\u308c\u307e\u3059\u3002\u73fe\u5728\u306e\u6cbb\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3082\u4e3b\u89817\u5e02\u5834\u5168\u4f53\u3067\u691c\u8a0e\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883\u306b\u3064\u3044\u3066\u306f\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u4f01\u696d\u306e\u7279\u5b9a\u3068\u305d\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3001MASH\u5e02\u5834\u306b\u95a2\u9023\u3059\u308b\u4e3b\u8981\u306a\u5408\u4f75\u30fb\u8cb7\u53ce\uff08M&#038;A\uff09\u3001\u30e9\u30a4\u30bb\u30f3\u30b9\u6d3b\u52d5\u3001\u63d0\u643a\u306a\u3069\u306e\u91cd\u8981\u306a\u4f01\u696d\u6d3b\u52d5\u3001\u304a\u3088\u3073\u4e3b\u8981\u306a\u898f\u5236\u30a4\u30d9\u30f3\u30c8\u3092\u7db2\u7f85\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3068\u4e3b\u8981\u30d7\u30ec\u30a4\u30e4\u30fc\u306e\u6226\u7565\u7684\u52d5\u304d\u304c\u660e\u78ba\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>\u3055\u3089\u306b\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u72b6\u6cc1\u3082\u3001\u305d\u306e\u30b9\u30c6\u30fc\u30bf\u30b9\u3001\u30d5\u30a7\u30fc\u30ba\u3001\u6295\u4e0e\u7d4c\u8def\u5225\u306b\u69cb\u9020\u3092\u5206\u6790\u3057\u3001MASH\u6cbb\u7642\u85ac\u958b\u767a\u306e\u73fe\u72b6\u3068\u5c06\u6765\u306e\u65b9\u5411\u6027\u3092\u6df1\u304f\u6398\u308a\u4e0b\u3052\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001MASH\u5e02\u5834\u304c\u3053\u308c\u307e\u3067\u3069\u306e\u3088\u3046\u306b\u63a8\u79fb\u3057\u3001\u4eca\u5f8c\u6570\u5e74\u9593\u3067\u3069\u306e\u3088\u3046\u306b\u5909\u5316\u3059\u308b\u304b\u30012024\u5e74\u306b\u304a\u3051\u308b\u69d8\u3005\u306a\u6cbb\u7642\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u30682035\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308bMASH\u5e02\u5834\u306e\u56fd\u5225\u898f\u6a21\u3068\u6210\u9577\u7387\u3001\u305d\u3057\u3066\u5e02\u5834\u306e\u4e3b\u8981\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3068\u3044\u3063\u305f\u3001\u91cd\u8981\u306a\u5e02\u5834\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u307e\u305f\u3001MASH\u306e\u6709\u75c5\u8005\u6570\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u60a3\u8005\u30d7\u30fc\u30eb\u306e\u4e88\u6e2c\u3001\u75ab\u5b66\u7684\u50be\u5411\u3092\u63a8\u9032\u3059\u308b\u4e3b\u8981\u56e0\u3001\u60a3\u8005\u6570\u306e\u6210\u9577\u7387\u3068\u3044\u3063\u305f\u75ab\u5b66\u30a4\u30f3\u30b5\u30a4\u30c8\u3082\u63d0\u4f9b\u3057\u307e\u3059\u3002\u73fe\u5728\u306e\u5e02\u8ca9\u85ac\u3068\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3001MASH\u5e02\u5834\u306b\u95a2\u9023\u3059\u308b\u4e3b\u8981\u306a\u4f01\u696d\u6d3b\u52d5\u3084\u898f\u5236\u30a4\u30d9\u30f3\u30c8\u306b\u95a2\u3059\u308b\u60c5\u5831\u3082\u7db2\u7f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u5305\u62ec\u7684\u306a\u5206\u6790\u306b\u3088\u308a\u3001MASH\u5e02\u5834\u306e\u9032\u5316\u3059\u308b\u72b6\u6cc1\u3001\u6cbb\u7642\u306e\u9032\u6b69\u3001\u304a\u3088\u3073\u5c06\u6765\u306e\u6a5f\u4f1a\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u6d1e\u5bdf\u304c\u5f97\u3089\u308c\u3001\u95a2\u4fc2\u8005\u304c\u60c5\u5831\u306b\u57fa\u3065\u3044\u305f\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u305f\u3081\u306e\u5f37\u56fa\u306a\u57fa\u76e4\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74\" \/>\n<meta property=\"og:description\" content=\"\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u306e7\u5927\u5e02\u5834\u306f\u30012024\u5e74\u306b25\u51046,280\u4e07\u7c73\u30c9\u30eb\u306e\u898f\u6a21\u306b\u9054\u3057\u307e\u3057\u305f\u3002IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u4e88\u6e2c\u306b\u3088\u308b\u3068\u3001\u3053\u306e\u5e02\u5834\u306f2035\u5e74\u307e\u3067\u306b213\u5104230\u4e07\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3057\u30012025\u5e74\u304b\u30892035\u5e74\u306e\u9593\u306b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0921.23%\u3092\u8a18\u9332\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002 MASH\u306f\u3001\u809d\u81d3\u306b\u8102\u80aa\u304c\u84c4\u7a4d\u3057\u3001\u708e\u75c7\u3092\u5f15\u304d\u8d77\u3053\u3057\u3066\u809d\u81d3\u306b\u640d\u50b7\u3092\u4e0e\u3048\u308b\u809d\u75be\u60a3\u3067\u3059\u3002\u9ad8\u8840\u7cd6\u3001\u80a5\u6e80\u3001\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u306a\u3069\u306e\u4ee3\u8b1d\u969c\u5bb3\u304c\u539f\u56e0\u3067\u767a\u751f\u3057\u3001\u591a\u91cf\u306e\u30a2\u30eb\u30b3\u30fc\u30eb\u6442\u53d6\u3092\u4f34\u308f\u306a\u3044\u8102\u80aa\u809d\u75be\u60a3\u306e\u4e00\u7a2e\u3067\u3059\u3002\u521d\u671f\u306b\u306f\u81ea\u899a\u75c7\u72b6\u304c\u306a\u3044\u3053\u3068\u3082\u591a\u304f\u3001\u75c7\u72b6\u304c\u73fe\u308c\u308b\u307e\u3067\u306b\u6570\u9031\u9593\u304b\u304b\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002\u4e2d\u7a0b\u5ea6\u306eMASH\u3067\u306f\u3001\u53f3\u4e0a\u8179\u90e8\u306e\u75db\u307f\u3001\u75b2\u52b4\u3001\u8131\u529b\u611f\u3001\u98df\u6b32\u4e0d\u632f\u3001\u539f\u56e0\u4e0d\u660e\u306e\u4f53\u91cd\u6e1b\u5c11\u304c\u898b\u3089\u308c\u307e\u3059\u3002\u9032\u884c\u3057\u305f\u30b1\u30fc\u30b9\u3067\u306f\u3001\u3042\u3056\u304c\u3067\u304d\u3084\u3059\u3044\u3001\u51fa\u8840\u3057\u3084\u3059\u3044\u3001\u809d\u4e0d\u5168\u306b\u3088\u308b\u9ec4\u75b8\u3001\u30ea\u30f3\u30d1\u7bc0\u306e\u816b\u308c\u3001\u6301\u7d9a\u7684\u306a\u304b\u3086\u307f\u3001\u809d\u81d3\u3084\u813e\u81d3\u306e\u80a5\u5927\u3001\u7cbe\u795e\u932f\u4e71\u3001\u7720\u6c17\u3001\u308d\u308c\u3064\u304c\u56de\u3089\u306a\u3044\u306a\u3069\u306e\u75c7\u72b6\u304c\u60aa\u5316\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u8a3a\u65ad\u306b\u306f\u3001\u81e8\u5e8a\u8a55\u4fa1\u3001\u5bb6\u65cf\u6b74\u3001\u8840\u6db2\u691c\u67fb\u3001\u809d\u81d3\u306e\u786c\u3055\u306e\u6e2c\u5b9a\u306b\u52a0\u3048\u3001\u8179\u90e8\u8d85\u97f3\u6ce2\u691c\u67fb\u3084CT\u30b9\u30ad\u30e3\u30f3\u306a\u3069\u306e\u753b\u50cf\u8a3a\u65ad\u304c\u7528\u3044\u3089\u308c\u3001\u809d\u81d3\u5185\u306e\u8102\u80aa\u306e\u5b58\u5728\u304c\u78ba\u8a8d\u3055\u308c\u307e\u3059\u3002 MASH\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3057\u3066\u3044\u308b\u306e\u306f\u3001\u80a5\u6e80\u3001\u9ad8\u8840\u5727\u3001\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u3092\u7279\u5fb4\u3068\u3057\u3001\u809d\u81d3\u3078\u306e\u8102\u80aa\u6c88\u7740\u3001\u708e\u75c7\u3001\u7622\u75d5\u5316\u3092\u5f15\u304d\u8d77\u3053\u3059\u4ee3\u8b1d\u75c7\u5019\u7fa4\u306e\u5897\u52a0\u3067\u3059\u3002\u307e\u305f\u3001\u30ec\u30e1\u30c1\u30ed\u30e0\u306a\u3069\u306eTHR-\u30d9\u30fc\u30bf\u30a2\u30b4\u30cb\u30b9\u30c8\u304c\u809d\u81d3\u306e\u8102\u8cea\u4ee3\u8b1d\u3092\u8abf\u7bc0\u3059\u308b\u3053\u3068\u3067\u75c5\u6c17\u306e\u9032\u884c\u3092\u9006\u8ee2\u3055\u305b\u308b\u52b9\u679c\u3082\u5e02\u5834\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u30d3\u30bf\u30df\u30f3E\u3001\u30aa\u30e1\u30ac3\u8102\u80aa\u9178\u3001\u30b7\u30ea\u30de\u30ea\u30f3\u306a\u3069\u306e\u6804\u990a\u88dc\u52a9\u98df\u54c1\u304c\u75c7\u72b6\u306e\u7de9\u548c\u3084\u809d\u81d3\u306e\u5065\u5eb7\u6539\u5584\u306b\u5f79\u7acb\u3064\u3068\u3055\u308c\u3001\u305d\u306e\u4f7f\u7528\u304c\u5897\u52a0\u3057\u3066\u3044\u308b\u3053\u3068\u3082\u6210\u9577\u8981\u56e0\u3067\u3059\u3002\u91cd\u5ea6\u306e\u80a5\u6e80\u306b\u5bfe\u3059\u308b\u30d0\u30a4\u30d1\u30b9\u624b\u8853\u306e\u53d7\u3051\u5165\u308c\u62e1\u5927\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3067\u3042\u308a\u3001\u3053\u306e\u624b\u8853\u306f\u30b0\u30eb\u30ab\u30b4\u30f3\u69d8\u30da\u30d7\u30c1\u30c9-1\u306a\u3069\u306e\u8178\u7ba1\u30db\u30eb\u30e2\u30f3\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u6539\u5584\u3057\u3001\u809d\u81d3\u306e\u708e\u75c7\u3092\u6291\u5236\u3057\u307e\u3059\u3002\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u306f\u3001\u5e79\u7d30\u80de\u7642\u6cd5\u3078\u306e\u610f\u8b58\u306e\u9ad8\u307e\u308a\u3082MASH\u5e02\u5834\u5168\u4f53\u306b\u52e2\u3044\u3092\u4e0e\u3048\u308b\u3067\u3057\u3087\u3046\u3002\u3053\u308c\u306f\u809d\u7d44\u7e54\u306e\u518d\u751f\u3001\u7dda\u7dad\u5316\u306e\u8efd\u6e1b\u3001\u809d\u6a5f\u80fd\u306e\u6539\u5584\u306e\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002 IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u65b0\u3057\u3044\u30ec\u30dd\u30fc\u30c8\u300cMetabolic Dysfunction-Associated Steatohepatitis Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035\u300d\u306f\u3001\u7c73\u56fd\u3001EU5\uff08\u30c9\u30a4\u30c4\u3001\u30b9\u30da\u30a4\u30f3\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\uff09\u3001\u304a\u3088\u3073\u65e5\u672c\u306eMASH\u5e02\u5834\u3092\u7db2\u7f85\u7684\u306b\u5206\u6790\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5206\u6790\u306b\u306f\u3001\u6cbb\u7642\u6cd5\u3001\u5e02\u8ca9\u85ac\u304a\u3088\u3073\u958b\u767a\u4e2d\u306e\u85ac\u5264\u3001\u500b\u5225\u7642\u6cd5\u306e\u30b7\u30a7\u30a2\u30017\u5927\u5e02\u5834\u5168\u4f53\u306e\u5e02\u5834\u5b9f\u7e3e\u3001\u4e3b\u8981\u4f01\u696d\u3068\u305d\u306e\u85ac\u5264\u306e\u5e02\u5834\u5b9f\u7e3e\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u307e\u305f\u30017\u5927\u5e02\u5834\u306b\u304a\u3051\u308b\u73fe\u5728\u304a\u3088\u3073\u5c06\u6765\u306e\u60a3\u8005\u6570\u3082\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u7c73\u56fd\u306fMASH\u306e\u60a3\u8005\u6570\u304c\u6700\u3082\u591a\u304f\u3001\u6cbb\u7642\u5e02\u5834\u3068\u3057\u3066\u3082\u6700\u5927\u3067\u3059\u3002\u3055\u3089\u306b\u3001\u73fe\u5728\u306e\u6cbb\u7642\u6cd5\/\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u3001\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\u3001\u8ab2\u984c\u3001\u6a5f\u4f1a\u3001\u511f\u9084\u30b7\u30ca\u30ea\u30aa\u3001\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u533b\u7642\u30cb\u30fc\u30ba\u306a\u3069\u3082\u5831\u544a\u66f8\u3067\u8a73\u8ff0\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u88fd\u9020\u696d\u8005\u3001\u6295\u8cc7\u5bb6\u3001\u30d3\u30b8\u30cd\u30b9\u6226\u7565\u5bb6\u3001\u7814\u7a76\u8005\u3001\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u3001\u304a\u3088\u3073MASH\u5e02\u5834\u306b\u95a2\u5fc3\u3092\u6301\u3064\u3059\u3079\u3066\u306e\u4eba\u3005\u306b\u3068\u3063\u3066\u5fc5\u8aad\u306e\u8cc7\u6599\u3067\u3059\u3002 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u5e02\u5834\u306f\u3001\u65b0\u305f\u306a\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u9032\u5c55\u306b\u3088\u308a\u3001\u6d3b\u767a\u306a\u52d5\u304d\u3092\u898b\u305b\u3066\u3044\u307e\u3059\u3002 \u6700\u8fd1\u306e\u4e3b\u306a\u9032\u5c55\u3068\u3057\u3066\u30012025\u5e741\u6708\u306b\u306fAkero Therapeutics\u793e\u304c\u3001MASH\u306b\u8d77\u56e0\u3059\u308b\u30c1\u30e3\u30a4\u30eb\u30c9\u30fb\u30d4\u30e5\u30fcA\u7d1a\u809d\u786c\u5909\uff08F4\uff09\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fefruxifermin\uff08EFX\uff09\u306e\u7b2c2b\u76f8SYMMETRY\u81e8\u5e8a\u8a66\u9a13\u306e96\u9031\u6642\u70b9\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30d9\u30fc\u30b9\u30e9\u30a4\u30f3\u306896\u9031\u76ee\u306e\u751f\u691c\u30c7\u30fc\u30bf\u304c\u3042\u308b\u60a3\u8005\uff08n=134\uff09\u306e\u3046\u3061\u300150mg\u306eEFX\u6295\u4e0e\u7fa4\uff08n=46\uff09\u3067\u306f39%\u304cMASH\u306e\u60aa\u5316\u3092\u4f34\u308f\u306a\u3044\u809d\u786c\u5909\u306e\u6539\u5584\u3092\u793a\u3057\u3001\u30d7\u30e9\u30bb\u30dc\u7fa4\uff08n=47\uff09\u306e15%\u3068\u6bd4\u8f03\u3057\u3066\u6709\u610f\u306a\u7d50\u679c\u3067\u3057\u305f\uff08p=0.009\uff09\u3002 2024\u5e7411\u6708\u306b\u306f\u300189bio\u793e\u304c\u9032\u884c\u6027\u7dda\u7dad\u75c7\u3068MASH\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fpegozafermin\u306e\u7b2c2b\u76f8ENLIVEN\u8a66\u9a13\u306e\u65b0\u305f\u306a\u30c7\u30fc\u30bf\u89e3\u6790\u3092\u516c\u958b\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u7d50\u679c\u306f\u3001pegozafermin\u304c\u60a3\u8005\u306eFAST\u30b9\u30b3\u30a2\u3092\u6539\u5584\u3057\u305f\u3060\u3051\u3067\u306a\u304f\u3001MASH\u306e\u5bdb\u89e3\u3068\u7dda\u7dad\u75c7\u306e\u6539\u5584\u306e\u4e21\u65b9\u3092\u9054\u6210\u3057\u3001\u9032\u884c\u6027MASH\u60a3\u8005\u306e\u6709\u671b\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3067\u3042\u308b\u3053\u3068\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002 \u3055\u3089\u306b\u30012024\u5e749\u6708\u306b\u306fAligos Therapeutics\u793e\u304c\u3001MASH\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fTHR-\u03b2\u30a2\u30b4\u30cb\u30b9\u30c8ALG-055009\u306e\u7b2c2a\u76f8HERALD\u8a66\u9a13\u3067\u6709\u671b\u306a\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002ALG-055009\u306e\u5168\u3066\u306e\u6295\u4e0e\u7fa4\u306b\u304a\u3044\u3066\u300112\u9031\u76ee\u304b\u3089MRI-\u30d7\u30ed\u30c8\u30f3\u5bc6\u5ea6\u8102\u80aa\u5206\u753b\uff08MRI-PDFF\uff09\u3067\u6e2c\u5b9a\u3055\u308c\u305f\u809d\u8102\u80aa\u306e\u6709\u610f\u306a\u6e1b\u5c11\u304c\u78ba\u8a8d\u3055\u308c\u3001\u4e3b\u8981\u76ee\u6a19\u3092\u9054\u6210\u3057\u307e\u3057\u305f\u3002 MASH\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306f\u3001\u3044\u304f\u3064\u304b\u306e\u4e3b\u8981\u306a\u85ac\u5264\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u300cRezdiffra\u300d\u306f\u3001\u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u809d\u7dda\u7dad\u75c7\u3092\u4f34\u3046MASH\u60a3\u8005\u306b\u5bfe\u3057\u3001\u98df\u4e8b\u3068\u904b\u52d5\u7642\u6cd5\u3068\u4f75\u7528\u3057\u3066\u6295\u4e0e\u3055\u308c\u307e\u3059\u3002\u4e3b\u306b\u809d\u81d3\u306e\u7d30\u80de\u3067\u767a\u73fe\u3059\u308b\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u30d9\u30fc\u30bf\u306e\u90e8\u5206\u4f5c\u52d5\u85ac\u3068\u3057\u3066\u6a5f\u80fd\u3057\u3001\u8102\u8cea\u4ee3\u8b1d\u306b\u95a2\u308f\u308b\u907a\u4f1d\u5b50\u3092\u8abf\u7bc0\u3059\u308b\u3053\u3068\u3067\u3001\u809d\u5185\u30c8\u30ea\u30b0\u30ea\u30bb\u30ea\u30c9\u3092\u6e1b\u5c11\u3055\u305b\u3001\u809d\u8102\u80aa\u3092\u4f4e\u6e1b\u3057\u3001\u809d\u81d3\u306e\u5065\u5eb7\u3092\u5897\u9032\u3057\u307e\u3059\u3002 89bio\u793e\u304c\u958b\u767a\u3057\u305f\u300cPegozafermin\u300d\u306f\u3001\u5929\u7136\u306b\u5b58\u5728\u3059\u308b\u7dda\u7dad\u82bd\u7d30\u80de\u5897\u6b96\u56e0\u5b5021\uff08FGF21\uff09\u3092\u6a21\u5023\u3057\u3066\u4f5c\u7528\u3057\u3001\u4e3b\u306b\u809d\u81d3\u3092\u6a19\u7684\u3068\u3057\u307e\u3059\u3002\u3053\u306e\u85ac\u5264\u306f\u6297\u708e\u75c7\u4f5c\u7528\u3068\u6297\u7dda\u7dad\u5316\u4f5c\u7528\u3092\u6301\u3061\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u9ad8\u3081\u3001\u30c8\u30ea\u30b0\u30ea\u30bb\u30ea\u30c9\u30ec\u30d9\u30eb\u3092\u4f4e\u4e0b\u3055\u305b\u307e\u3059\u3002\u809d\u7dda\u7dad\u75c7\u3068\u708e\u75c7\u306e\u4e3b\u8981\u306a\u8981\u56e0\u3092\u6a19\u7684\u3068\u3059\u308b\u3053\u3068\u3067MASH\u306e\u6cbb\u7642\u3092\u52a9\u3051\u3001\u30a2\u30c7\u30a3\u30dd\u30cd\u30af\u30c1\u30f3\u5408\u6210\u306e\u4fc3\u9032\u3084\u809d\u81d3\u306b\u304a\u3051\u308b\u904a\u96e2\u8102\u80aa\u9178\u7ba1\u7406\u306e\u5f37\u5316\u3068\u3044\u3063\u305f\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u542b\u307f\u307e\u3059\u3002 Akero Therapeutics\u793e\u304c\u958b\u767a\u3057\u305f\u300cEfruxifermin\u300d\u3082\u3001\u4ee3\u8b1d\u30db\u30eb\u30e2\u30f3\u3067\u3042\u308b\u7dda\u7dad\u82bd\u7d30\u80de\u5897\u6b96\u56e0\u5b5021\uff08FGF21\uff09\u306e\u5929\u7136\u306e\u6d3b\u6027\u3092\u6a21\u5023\u3057\u307e\u3059\u3002\u809d\u81d3\u304a\u3088\u3073\u8102\u80aa\u7d44\u7e54\u306e\u7d30\u80de\u306b\u3042\u308b\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3057\u3066\u4ee3\u8b1d\u7d4c\u8def\u3092\u5909\u5316\u3055\u305b\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3001\u708e\u75c7\u3001\u7dda\u7dad\u5316\u3068\u3044\u3063\u305fMASH\u306e\u7279\u5fb4\u3092\u6e1b\u5c11\u3055\u305b\u307e\u3059\u3002\u672c\u8cea\u7684\u306bFGF21\u30a2\u30b4\u30cb\u30b9\u30c8\u3068\u3057\u3066\u6a5f\u80fd\u3057\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3068\u8102\u8cea\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6539\u5584\u3057\u306a\u304c\u3089\u3001\u5168\u8eab\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3067MASH\u75be\u60a3\u9032\u884c\u306e\u591a\u304f\u306e\u8981\u7d20\u306b\u5bfe\u51e6\u3057\u307e\u3059\u3002 Corcept Therapeutics\u793e\u304c\u958b\u767a\u3057\u305f\u300cMiricorilant\u300d\u306f\u3001\u9078\u629e\u7684\u30b0\u30eb\u30b3\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u30e2\u30b8\u30e5\u30ec\u30fc\u30bf\u30fc\uff08SGRM\uff09\u304a\u3088\u3073\u30df\u30cd\u30e9\u30eb\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\u3068\u3057\u3066\u4f5c\u7528\u3057\u307e\u3059\u3002\u4e3b\u306b\u809d\u81d3\u306e\u3053\u308c\u3089\u306e\u53d7\u5bb9\u4f53\u3068\u306e\u76f8\u4e92\u4f5c\u7528\u3092\u901a\u3058\u3066\u3001\u809d\u8102\u80aa\u306e\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3001\u4ee3\u8b1d\u6307\u6a19\u3092\u6539\u5584\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u3001MASH\u306e\u6f5c\u5728\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u306a\u308a\u5f97\u307e\u3059\u3002 \u300cALG-055009\u300d\u306f\u3001MASH\u306e\u7ba1\u7406\u3092\u76ee\u7684\u3068\u3057\u305f\u30af\u30e9\u30b9\u6700\u9ad8\u306e\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u30d9\u30fc\u30bf\u4f5c\u52d5\u85ac\u3067\u3059\u3002\u8102\u8cea\u4ee3\u8b1d\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u3067\u3042\u308bAPOC3\u306e\u963b\u5bb3\u3092\u901a\u3058\u3066\u305d\u306e\u52b9\u679c\u3092\u767a\u63ee\u3057\u307e\u3059\u3002ALG-055009\u306b\u3088\u308bAPOC3\u306e\u963b\u5bb3\u306f\u3001\u6b63\u5e38\u306a\u8102\u8cea\u4ee3\u8b1d\u3092\u56de\u5fa9\u3055\u305b\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3066\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u9ad8\u3081\u3001\u305d\u308c\u306b\u3088\u308a\u708e\u75c7\u3068\u7dda\u7dad\u5316\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u307e\u3059\u3002 \u672c\u7814\u7a76\u306e\u5bfe\u8c61\u671f\u9593\u306f\u3001\u57fa\u6e96\u5e74\u304c2024\u5e74\u3001\u904e\u53bb\u671f\u9593\u304c2019\u5e74\u304b\u30892024\u5e74\u3001\u5e02\u5834\u4e88\u6e2c\u671f\u9593\u304c2025\u5e74\u304b\u30892035\u5e74\u3067\u3059\u3002\u5bfe\u8c61\u56fd\u306f\u7c73\u56fd\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u65e5\u672c\u304c\u542b\u307e\u308c\u3001\u5404\u56fd\u306b\u304a\u3051\u308b\u904e\u53bb\u3001\u73fe\u5728\u3001\u304a\u3088\u3073\u4e88\u6e2c\u5206\u6790\u304c\u30ab\u30d0\u30fc\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u904e\u53bb\u3001\u73fe\u5728\u3001\u305d\u3057\u3066\u5c06\u6765\u306b\u308f\u305f\u308b\u5e02\u5834\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u3001\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa\u3001\u304a\u3088\u3073\u69d8\u3005\u306a\u6cbb\u7642\u30ab\u30c6\u30b4\u30ea\u30fc\u306e\u52d5\u5411\u3092\u8a73\u7d30\u306b\u8a55\u4fa1\u3057\u307e\u3059\u3002 \u75ab\u5b66\u306e\u5074\u9762\u3067\u306f\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308bMASH\u306e\u6709\u75c5\u8005\u6570\uff082019-2035\u5e74\uff09\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u60a3\u8005\u30d7\u30fc\u30eb\u3092\u3001\u5e74\u9f62\u5225\u3001\u6027\u5225\u3092\u542b\u3080\u8a73\u7d30\u306a\u30c7\u30fc\u30bf\u3067\u5206\u6790\u3057\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u30012019\u5e74\u304b\u30892035\u5e74\u307e\u3067\u306e\u6709\u75c5\u8005\u6570\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u305d\u3057\u30662019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u60a3\u8005\u30d7\u30fc\u30eb\u898f\u6a21\u30682025\u5e74\u304b\u30892035\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u60a3\u8005\u30d7\u30fc\u30eb\u304c\u63d0\u793a\u3055\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u75ab\u5b66\u7684\u50be\u5411\u3092\u63a8\u9032\u3059\u308b\u4e3b\u8981\u56e0\u3068\u60a3\u8005\u6570\u306e\u6210\u9577\u7387\u3082\u4e88\u6e2c\u3057\u3001MASH\u306e\u75be\u60a3\u8ca0\u62c5\u306b\u95a2\u3059\u308b\u6df1\u3044\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002 \u5e02\u5834\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306b\u3064\u3044\u3066\u306f\u3001MASH\u5e02\u5834\u5168\u4f53\u306e\u904e\u53bb\u3001\u73fe\u5728\u3001\u5c06\u6765\u306e\u52d5\u5411\u3092\u8a55\u4fa1\u3057\u3001\u69d8\u3005\u306a\u6cbb\u7642\u30ab\u30c6\u30b4\u30ea\u30fc\u306e\u5e02\u5834\u30b7\u30a7\u30a2\uff082024\u5e74\u304a\u3088\u30732035\u5e74\u4e88\u6e2c\uff09\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308b\u5404\u56fd\u5225\u306eMASH\u5e02\u5834\u898f\u6a21\uff082024\u5e74\u304a\u3088\u30732035\u5e74\u4e88\u6e2c\uff09\u3001\u5e02\u5834\u306e\u6210\u9577\u7387\u3001\u305d\u3057\u3066\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3092\u660e\u3089\u304b\u306b\u3057\u307e\u3059\u3002\u69d8\u3005\u306a\u85ac\u5264\u306e\u58f2\u4e0a\u9ad8\u3084\u511f\u9084\u30b7\u30ca\u30ea\u30aa\u3082\u8a73\u7d30\u306b\u5206\u6790\u5bfe\u8c61\u3068\u306a\u308a\u307e\u3059\u3002 \u6cbb\u7642\u85ac\u306e\u72b6\u6cc1\u3068\u3057\u3066\u3001\u73fe\u5728\u5e02\u8ca9\u3055\u308c\u3066\u3044\u308b\u85ac\u5264\u3068\u5f8c\u671f\u6bb5\u968e\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u5264\u306e\u4e21\u65b9\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u3001\u5404\u85ac\u5264\u306e\u6982\u8981\u3001\u4f5c\u7528\u6a5f\u5e8f\u3001\u898f\u5236\u72b6\u6cc1\u3001\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3001\u85ac\u5264\u306e\u666e\u53ca\u72b6\u6cc1\u3001\u5e02\u5834\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u3001Madrigal Pharmaceuticals\u306eRezdiffra\uff08Resmetirom\uff09\u300189bio\u306ePegozafermin\u3001Akero Therapeutics\u306eEfruxifermin\u3001Corcept Therapeutics\u306eMiricorilant\u3001Aligos Therapeutics\u306eALG-055009\u3001Regeneron Pharmaceuticals\u306eALN-HSD\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u3053\u308c\u3089\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3082\u8a55\u4fa1\u3055\u308c\u307e\u3059\u3002\u73fe\u5728\u306e\u6cbb\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3082\u4e3b\u89817\u5e02\u5834\u5168\u4f53\u3067\u691c\u8a0e\u3055\u308c\u307e\u3059\u3002 \u7af6\u4e89\u74b0\u5883\u306b\u3064\u3044\u3066\u306f\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u4f01\u696d\u306e\u7279\u5b9a\u3068\u305d\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3001MASH\u5e02\u5834\u306b\u95a2\u9023\u3059\u308b\u4e3b\u8981\u306a\u5408\u4f75\u30fb\u8cb7\u53ce\uff08M&amp;A\uff09\u3001\u30e9\u30a4\u30bb\u30f3\u30b9\u6d3b\u52d5\u3001\u63d0\u643a\u306a\u3069\u306e\u91cd\u8981\u306a\u4f01\u696d\u6d3b\u52d5\u3001\u304a\u3088\u3073\u4e3b\u8981\u306a\u898f\u5236\u30a4\u30d9\u30f3\u30c8\u3092\u7db2\u7f85\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3068\u4e3b\u8981\u30d7\u30ec\u30a4\u30e4\u30fc\u306e\u6226\u7565\u7684\u52d5\u304d\u304c\u660e\u78ba\u306b\u306a\u308a\u307e\u3059\u3002 \u3055\u3089\u306b\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u72b6\u6cc1\u3082\u3001\u305d\u306e\u30b9\u30c6\u30fc\u30bf\u30b9\u3001\u30d5\u30a7\u30fc\u30ba\u3001\u6295\u4e0e\u7d4c\u8def\u5225\u306b\u69cb\u9020\u3092\u5206\u6790\u3057\u3001MASH\u6cbb\u7642\u85ac\u958b\u767a\u306e\u73fe\u72b6\u3068\u5c06\u6765\u306e\u65b9\u5411\u6027\u3092\u6df1\u304f\u6398\u308a\u4e0b\u3052\u307e\u3059\u3002 \u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001MASH\u5e02\u5834\u304c\u3053\u308c\u307e\u3067\u3069\u306e\u3088\u3046\u306b\u63a8\u79fb\u3057\u3001\u4eca\u5f8c\u6570\u5e74\u9593\u3067\u3069\u306e\u3088\u3046\u306b\u5909\u5316\u3059\u308b\u304b\u30012024\u5e74\u306b\u304a\u3051\u308b\u69d8\u3005\u306a\u6cbb\u7642\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u30682035\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308bMASH\u5e02\u5834\u306e\u56fd\u5225\u898f\u6a21\u3068\u6210\u9577\u7387\u3001\u305d\u3057\u3066\u5e02\u5834\u306e\u4e3b\u8981\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3068\u3044\u3063\u305f\u3001\u91cd\u8981\u306a\u5e02\u5834\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u307e\u305f\u3001MASH\u306e\u6709\u75c5\u8005\u6570\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u60a3\u8005\u30d7\u30fc\u30eb\u306e\u4e88\u6e2c\u3001\u75ab\u5b66\u7684\u50be\u5411\u3092\u63a8\u9032\u3059\u308b\u4e3b\u8981\u56e0\u3001\u60a3\u8005\u6570\u306e\u6210\u9577\u7387\u3068\u3044\u3063\u305f\u75ab\u5b66\u30a4\u30f3\u30b5\u30a4\u30c8\u3082\u63d0\u4f9b\u3057\u307e\u3059\u3002\u73fe\u5728\u306e\u5e02\u8ca9\u85ac\u3068\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3001MASH\u5e02\u5834\u306b\u95a2\u9023\u3059\u308b\u4e3b\u8981\u306a\u4f01\u696d\u6d3b\u52d5\u3084\u898f\u5236\u30a4\u30d9\u30f3\u30c8\u306b\u95a2\u3059\u308b\u60c5\u5831\u3082\u7db2\u7f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u3053\u306e\u5305\u62ec\u7684\u306a\u5206\u6790\u306b\u3088\u308a\u3001MASH\u5e02\u5834\u306e\u9032\u5316\u3059\u308b\u72b6\u6cc1\u3001\u6cbb\u7642\u306e\u9032\u6b69\u3001\u304a\u3088\u3073\u5c06\u6765\u306e\u6a5f\u4f1a\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u6d1e\u5bdf\u304c\u5f97\u3089\u308c\u3001\u95a2\u4fc2\u8005\u304c\u60c5\u5831\u306b\u57fa\u3065\u3044\u305f\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u305f\u3081\u306e\u5f37\u56fa\u306a\u57fa\u76e4\u3068\u306a\u308a\u307e\u3059\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/\" \/>\n<meta property=\"og:site_name\" content=\"GlobalResearch.jp\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-14T15:30:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T02:09:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp\" \/>\n<meta name=\"author\" content=\"globalresearch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"globalresearch\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/\",\"url\":\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/\",\"name\":\"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74\",\"isPartOf\":{\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp\",\"datePublished\":\"2026-02-14T15:30:24+00:00\",\"dateModified\":\"2026-02-24T02:09:38+00:00\",\"author\":{\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#primaryimage\",\"url\":\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp\",\"contentUrl\":\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/www.globalresearch.jp\/data\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#website\",\"url\":\"https:\/\/www.marketreport.jp\/insight\/\",\"name\":\"GlobalResearch.jp\",\"description\":\"\u2756\u30b0\u30ed\u30fc\u30d0\u30eb\u8abf\u67fb\u30ec\u30dd\u30fc\u30c8\u8ca9\u58f2\u30b5\u30a4\u30c8\u2756\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.marketreport.jp\/insight\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4\",\"name\":\"globalresearch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g\",\"caption\":\"globalresearch\"},\"sameAs\":[\"https:\/\/www.marketreport.jp\/insight\"],\"url\":\"https:\/\/www.globalresearch.jp\/data\/author\/globalresearch\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/","og_locale":"ja_JP","og_type":"article","og_title":"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74","og_description":"\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u306e7\u5927\u5e02\u5834\u306f\u30012024\u5e74\u306b25\u51046,280\u4e07\u7c73\u30c9\u30eb\u306e\u898f\u6a21\u306b\u9054\u3057\u307e\u3057\u305f\u3002IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u4e88\u6e2c\u306b\u3088\u308b\u3068\u3001\u3053\u306e\u5e02\u5834\u306f2035\u5e74\u307e\u3067\u306b213\u5104230\u4e07\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3057\u30012025\u5e74\u304b\u30892035\u5e74\u306e\u9593\u306b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0921.23%\u3092\u8a18\u9332\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002 MASH\u306f\u3001\u809d\u81d3\u306b\u8102\u80aa\u304c\u84c4\u7a4d\u3057\u3001\u708e\u75c7\u3092\u5f15\u304d\u8d77\u3053\u3057\u3066\u809d\u81d3\u306b\u640d\u50b7\u3092\u4e0e\u3048\u308b\u809d\u75be\u60a3\u3067\u3059\u3002\u9ad8\u8840\u7cd6\u3001\u80a5\u6e80\u3001\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u306a\u3069\u306e\u4ee3\u8b1d\u969c\u5bb3\u304c\u539f\u56e0\u3067\u767a\u751f\u3057\u3001\u591a\u91cf\u306e\u30a2\u30eb\u30b3\u30fc\u30eb\u6442\u53d6\u3092\u4f34\u308f\u306a\u3044\u8102\u80aa\u809d\u75be\u60a3\u306e\u4e00\u7a2e\u3067\u3059\u3002\u521d\u671f\u306b\u306f\u81ea\u899a\u75c7\u72b6\u304c\u306a\u3044\u3053\u3068\u3082\u591a\u304f\u3001\u75c7\u72b6\u304c\u73fe\u308c\u308b\u307e\u3067\u306b\u6570\u9031\u9593\u304b\u304b\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002\u4e2d\u7a0b\u5ea6\u306eMASH\u3067\u306f\u3001\u53f3\u4e0a\u8179\u90e8\u306e\u75db\u307f\u3001\u75b2\u52b4\u3001\u8131\u529b\u611f\u3001\u98df\u6b32\u4e0d\u632f\u3001\u539f\u56e0\u4e0d\u660e\u306e\u4f53\u91cd\u6e1b\u5c11\u304c\u898b\u3089\u308c\u307e\u3059\u3002\u9032\u884c\u3057\u305f\u30b1\u30fc\u30b9\u3067\u306f\u3001\u3042\u3056\u304c\u3067\u304d\u3084\u3059\u3044\u3001\u51fa\u8840\u3057\u3084\u3059\u3044\u3001\u809d\u4e0d\u5168\u306b\u3088\u308b\u9ec4\u75b8\u3001\u30ea\u30f3\u30d1\u7bc0\u306e\u816b\u308c\u3001\u6301\u7d9a\u7684\u306a\u304b\u3086\u307f\u3001\u809d\u81d3\u3084\u813e\u81d3\u306e\u80a5\u5927\u3001\u7cbe\u795e\u932f\u4e71\u3001\u7720\u6c17\u3001\u308d\u308c\u3064\u304c\u56de\u3089\u306a\u3044\u306a\u3069\u306e\u75c7\u72b6\u304c\u60aa\u5316\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u8a3a\u65ad\u306b\u306f\u3001\u81e8\u5e8a\u8a55\u4fa1\u3001\u5bb6\u65cf\u6b74\u3001\u8840\u6db2\u691c\u67fb\u3001\u809d\u81d3\u306e\u786c\u3055\u306e\u6e2c\u5b9a\u306b\u52a0\u3048\u3001\u8179\u90e8\u8d85\u97f3\u6ce2\u691c\u67fb\u3084CT\u30b9\u30ad\u30e3\u30f3\u306a\u3069\u306e\u753b\u50cf\u8a3a\u65ad\u304c\u7528\u3044\u3089\u308c\u3001\u809d\u81d3\u5185\u306e\u8102\u80aa\u306e\u5b58\u5728\u304c\u78ba\u8a8d\u3055\u308c\u307e\u3059\u3002 MASH\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3057\u3066\u3044\u308b\u306e\u306f\u3001\u80a5\u6e80\u3001\u9ad8\u8840\u5727\u3001\u9ad8\u30b3\u30ec\u30b9\u30c6\u30ed\u30fc\u30eb\u3092\u7279\u5fb4\u3068\u3057\u3001\u809d\u81d3\u3078\u306e\u8102\u80aa\u6c88\u7740\u3001\u708e\u75c7\u3001\u7622\u75d5\u5316\u3092\u5f15\u304d\u8d77\u3053\u3059\u4ee3\u8b1d\u75c7\u5019\u7fa4\u306e\u5897\u52a0\u3067\u3059\u3002\u307e\u305f\u3001\u30ec\u30e1\u30c1\u30ed\u30e0\u306a\u3069\u306eTHR-\u30d9\u30fc\u30bf\u30a2\u30b4\u30cb\u30b9\u30c8\u304c\u809d\u81d3\u306e\u8102\u8cea\u4ee3\u8b1d\u3092\u8abf\u7bc0\u3059\u308b\u3053\u3068\u3067\u75c5\u6c17\u306e\u9032\u884c\u3092\u9006\u8ee2\u3055\u305b\u308b\u52b9\u679c\u3082\u5e02\u5834\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u30d3\u30bf\u30df\u30f3E\u3001\u30aa\u30e1\u30ac3\u8102\u80aa\u9178\u3001\u30b7\u30ea\u30de\u30ea\u30f3\u306a\u3069\u306e\u6804\u990a\u88dc\u52a9\u98df\u54c1\u304c\u75c7\u72b6\u306e\u7de9\u548c\u3084\u809d\u81d3\u306e\u5065\u5eb7\u6539\u5584\u306b\u5f79\u7acb\u3064\u3068\u3055\u308c\u3001\u305d\u306e\u4f7f\u7528\u304c\u5897\u52a0\u3057\u3066\u3044\u308b\u3053\u3068\u3082\u6210\u9577\u8981\u56e0\u3067\u3059\u3002\u91cd\u5ea6\u306e\u80a5\u6e80\u306b\u5bfe\u3059\u308b\u30d0\u30a4\u30d1\u30b9\u624b\u8853\u306e\u53d7\u3051\u5165\u308c\u62e1\u5927\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3067\u3042\u308a\u3001\u3053\u306e\u624b\u8853\u306f\u30b0\u30eb\u30ab\u30b4\u30f3\u69d8\u30da\u30d7\u30c1\u30c9-1\u306a\u3069\u306e\u8178\u7ba1\u30db\u30eb\u30e2\u30f3\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u6539\u5584\u3057\u3001\u809d\u81d3\u306e\u708e\u75c7\u3092\u6291\u5236\u3057\u307e\u3059\u3002\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u306f\u3001\u5e79\u7d30\u80de\u7642\u6cd5\u3078\u306e\u610f\u8b58\u306e\u9ad8\u307e\u308a\u3082MASH\u5e02\u5834\u5168\u4f53\u306b\u52e2\u3044\u3092\u4e0e\u3048\u308b\u3067\u3057\u3087\u3046\u3002\u3053\u308c\u306f\u809d\u7d44\u7e54\u306e\u518d\u751f\u3001\u7dda\u7dad\u5316\u306e\u8efd\u6e1b\u3001\u809d\u6a5f\u80fd\u306e\u6539\u5584\u306e\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u307e\u3059\u3002 IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u65b0\u3057\u3044\u30ec\u30dd\u30fc\u30c8\u300cMetabolic Dysfunction-Associated Steatohepatitis Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035\u300d\u306f\u3001\u7c73\u56fd\u3001EU5\uff08\u30c9\u30a4\u30c4\u3001\u30b9\u30da\u30a4\u30f3\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\uff09\u3001\u304a\u3088\u3073\u65e5\u672c\u306eMASH\u5e02\u5834\u3092\u7db2\u7f85\u7684\u306b\u5206\u6790\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5206\u6790\u306b\u306f\u3001\u6cbb\u7642\u6cd5\u3001\u5e02\u8ca9\u85ac\u304a\u3088\u3073\u958b\u767a\u4e2d\u306e\u85ac\u5264\u3001\u500b\u5225\u7642\u6cd5\u306e\u30b7\u30a7\u30a2\u30017\u5927\u5e02\u5834\u5168\u4f53\u306e\u5e02\u5834\u5b9f\u7e3e\u3001\u4e3b\u8981\u4f01\u696d\u3068\u305d\u306e\u85ac\u5264\u306e\u5e02\u5834\u5b9f\u7e3e\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u307e\u305f\u30017\u5927\u5e02\u5834\u306b\u304a\u3051\u308b\u73fe\u5728\u304a\u3088\u3073\u5c06\u6765\u306e\u60a3\u8005\u6570\u3082\u63d0\u4f9b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30ec\u30dd\u30fc\u30c8\u306b\u3088\u308b\u3068\u3001\u7c73\u56fd\u306fMASH\u306e\u60a3\u8005\u6570\u304c\u6700\u3082\u591a\u304f\u3001\u6cbb\u7642\u5e02\u5834\u3068\u3057\u3066\u3082\u6700\u5927\u3067\u3059\u3002\u3055\u3089\u306b\u3001\u73fe\u5728\u306e\u6cbb\u7642\u6cd5\/\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u3001\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\u3001\u8ab2\u984c\u3001\u6a5f\u4f1a\u3001\u511f\u9084\u30b7\u30ca\u30ea\u30aa\u3001\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u533b\u7642\u30cb\u30fc\u30ba\u306a\u3069\u3082\u5831\u544a\u66f8\u3067\u8a73\u8ff0\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u88fd\u9020\u696d\u8005\u3001\u6295\u8cc7\u5bb6\u3001\u30d3\u30b8\u30cd\u30b9\u6226\u7565\u5bb6\u3001\u7814\u7a76\u8005\u3001\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u3001\u304a\u3088\u3073MASH\u5e02\u5834\u306b\u95a2\u5fc3\u3092\u6301\u3064\u3059\u3079\u3066\u306e\u4eba\u3005\u306b\u3068\u3063\u3066\u5fc5\u8aad\u306e\u8cc7\u6599\u3067\u3059\u3002 \u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u5e02\u5834\u306f\u3001\u65b0\u305f\u306a\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u9032\u5c55\u306b\u3088\u308a\u3001\u6d3b\u767a\u306a\u52d5\u304d\u3092\u898b\u305b\u3066\u3044\u307e\u3059\u3002 \u6700\u8fd1\u306e\u4e3b\u306a\u9032\u5c55\u3068\u3057\u3066\u30012025\u5e741\u6708\u306b\u306fAkero Therapeutics\u793e\u304c\u3001MASH\u306b\u8d77\u56e0\u3059\u308b\u30c1\u30e3\u30a4\u30eb\u30c9\u30fb\u30d4\u30e5\u30fcA\u7d1a\u809d\u786c\u5909\uff08F4\uff09\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fefruxifermin\uff08EFX\uff09\u306e\u7b2c2b\u76f8SYMMETRY\u81e8\u5e8a\u8a66\u9a13\u306e96\u9031\u6642\u70b9\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30d9\u30fc\u30b9\u30e9\u30a4\u30f3\u306896\u9031\u76ee\u306e\u751f\u691c\u30c7\u30fc\u30bf\u304c\u3042\u308b\u60a3\u8005\uff08n=134\uff09\u306e\u3046\u3061\u300150mg\u306eEFX\u6295\u4e0e\u7fa4\uff08n=46\uff09\u3067\u306f39%\u304cMASH\u306e\u60aa\u5316\u3092\u4f34\u308f\u306a\u3044\u809d\u786c\u5909\u306e\u6539\u5584\u3092\u793a\u3057\u3001\u30d7\u30e9\u30bb\u30dc\u7fa4\uff08n=47\uff09\u306e15%\u3068\u6bd4\u8f03\u3057\u3066\u6709\u610f\u306a\u7d50\u679c\u3067\u3057\u305f\uff08p=0.009\uff09\u3002 2024\u5e7411\u6708\u306b\u306f\u300189bio\u793e\u304c\u9032\u884c\u6027\u7dda\u7dad\u75c7\u3068MASH\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fpegozafermin\u306e\u7b2c2b\u76f8ENLIVEN\u8a66\u9a13\u306e\u65b0\u305f\u306a\u30c7\u30fc\u30bf\u89e3\u6790\u3092\u516c\u958b\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u7d50\u679c\u306f\u3001pegozafermin\u304c\u60a3\u8005\u306eFAST\u30b9\u30b3\u30a2\u3092\u6539\u5584\u3057\u305f\u3060\u3051\u3067\u306a\u304f\u3001MASH\u306e\u5bdb\u89e3\u3068\u7dda\u7dad\u75c7\u306e\u6539\u5584\u306e\u4e21\u65b9\u3092\u9054\u6210\u3057\u3001\u9032\u884c\u6027MASH\u60a3\u8005\u306e\u6709\u671b\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3067\u3042\u308b\u3053\u3068\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002 \u3055\u3089\u306b\u30012024\u5e749\u6708\u306b\u306fAligos Therapeutics\u793e\u304c\u3001MASH\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fTHR-\u03b2\u30a2\u30b4\u30cb\u30b9\u30c8ALG-055009\u306e\u7b2c2a\u76f8HERALD\u8a66\u9a13\u3067\u6709\u671b\u306a\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002ALG-055009\u306e\u5168\u3066\u306e\u6295\u4e0e\u7fa4\u306b\u304a\u3044\u3066\u300112\u9031\u76ee\u304b\u3089MRI-\u30d7\u30ed\u30c8\u30f3\u5bc6\u5ea6\u8102\u80aa\u5206\u753b\uff08MRI-PDFF\uff09\u3067\u6e2c\u5b9a\u3055\u308c\u305f\u809d\u8102\u80aa\u306e\u6709\u610f\u306a\u6e1b\u5c11\u304c\u78ba\u8a8d\u3055\u308c\u3001\u4e3b\u8981\u76ee\u6a19\u3092\u9054\u6210\u3057\u307e\u3057\u305f\u3002 MASH\u6cbb\u7642\u85ac\u3068\u3057\u3066\u306f\u3001\u3044\u304f\u3064\u304b\u306e\u4e3b\u8981\u306a\u85ac\u5264\u304c\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u300cRezdiffra\u300d\u306f\u3001\u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u809d\u7dda\u7dad\u75c7\u3092\u4f34\u3046MASH\u60a3\u8005\u306b\u5bfe\u3057\u3001\u98df\u4e8b\u3068\u904b\u52d5\u7642\u6cd5\u3068\u4f75\u7528\u3057\u3066\u6295\u4e0e\u3055\u308c\u307e\u3059\u3002\u4e3b\u306b\u809d\u81d3\u306e\u7d30\u80de\u3067\u767a\u73fe\u3059\u308b\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u30d9\u30fc\u30bf\u306e\u90e8\u5206\u4f5c\u52d5\u85ac\u3068\u3057\u3066\u6a5f\u80fd\u3057\u3001\u8102\u8cea\u4ee3\u8b1d\u306b\u95a2\u308f\u308b\u907a\u4f1d\u5b50\u3092\u8abf\u7bc0\u3059\u308b\u3053\u3068\u3067\u3001\u809d\u5185\u30c8\u30ea\u30b0\u30ea\u30bb\u30ea\u30c9\u3092\u6e1b\u5c11\u3055\u305b\u3001\u809d\u8102\u80aa\u3092\u4f4e\u6e1b\u3057\u3001\u809d\u81d3\u306e\u5065\u5eb7\u3092\u5897\u9032\u3057\u307e\u3059\u3002 89bio\u793e\u304c\u958b\u767a\u3057\u305f\u300cPegozafermin\u300d\u306f\u3001\u5929\u7136\u306b\u5b58\u5728\u3059\u308b\u7dda\u7dad\u82bd\u7d30\u80de\u5897\u6b96\u56e0\u5b5021\uff08FGF21\uff09\u3092\u6a21\u5023\u3057\u3066\u4f5c\u7528\u3057\u3001\u4e3b\u306b\u809d\u81d3\u3092\u6a19\u7684\u3068\u3057\u307e\u3059\u3002\u3053\u306e\u85ac\u5264\u306f\u6297\u708e\u75c7\u4f5c\u7528\u3068\u6297\u7dda\u7dad\u5316\u4f5c\u7528\u3092\u6301\u3061\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u9ad8\u3081\u3001\u30c8\u30ea\u30b0\u30ea\u30bb\u30ea\u30c9\u30ec\u30d9\u30eb\u3092\u4f4e\u4e0b\u3055\u305b\u307e\u3059\u3002\u809d\u7dda\u7dad\u75c7\u3068\u708e\u75c7\u306e\u4e3b\u8981\u306a\u8981\u56e0\u3092\u6a19\u7684\u3068\u3059\u308b\u3053\u3068\u3067MASH\u306e\u6cbb\u7642\u3092\u52a9\u3051\u3001\u30a2\u30c7\u30a3\u30dd\u30cd\u30af\u30c1\u30f3\u5408\u6210\u306e\u4fc3\u9032\u3084\u809d\u81d3\u306b\u304a\u3051\u308b\u904a\u96e2\u8102\u80aa\u9178\u7ba1\u7406\u306e\u5f37\u5316\u3068\u3044\u3063\u305f\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u542b\u307f\u307e\u3059\u3002 Akero Therapeutics\u793e\u304c\u958b\u767a\u3057\u305f\u300cEfruxifermin\u300d\u3082\u3001\u4ee3\u8b1d\u30db\u30eb\u30e2\u30f3\u3067\u3042\u308b\u7dda\u7dad\u82bd\u7d30\u80de\u5897\u6b96\u56e0\u5b5021\uff08FGF21\uff09\u306e\u5929\u7136\u306e\u6d3b\u6027\u3092\u6a21\u5023\u3057\u307e\u3059\u3002\u809d\u81d3\u304a\u3088\u3073\u8102\u80aa\u7d44\u7e54\u306e\u7d30\u80de\u306b\u3042\u308b\u53d7\u5bb9\u4f53\u306b\u7d50\u5408\u3057\u3066\u4ee3\u8b1d\u7d4c\u8def\u3092\u5909\u5316\u3055\u305b\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3001\u708e\u75c7\u3001\u7dda\u7dad\u5316\u3068\u3044\u3063\u305fMASH\u306e\u7279\u5fb4\u3092\u6e1b\u5c11\u3055\u305b\u307e\u3059\u3002\u672c\u8cea\u7684\u306bFGF21\u30a2\u30b4\u30cb\u30b9\u30c8\u3068\u3057\u3066\u6a5f\u80fd\u3057\u3001\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3068\u8102\u8cea\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u6539\u5584\u3057\u306a\u304c\u3089\u3001\u5168\u8eab\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3067MASH\u75be\u60a3\u9032\u884c\u306e\u591a\u304f\u306e\u8981\u7d20\u306b\u5bfe\u51e6\u3057\u307e\u3059\u3002 Corcept Therapeutics\u793e\u304c\u958b\u767a\u3057\u305f\u300cMiricorilant\u300d\u306f\u3001\u9078\u629e\u7684\u30b0\u30eb\u30b3\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u30e2\u30b8\u30e5\u30ec\u30fc\u30bf\u30fc\uff08SGRM\uff09\u304a\u3088\u3073\u30df\u30cd\u30e9\u30eb\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac\u3068\u3057\u3066\u4f5c\u7528\u3057\u307e\u3059\u3002\u4e3b\u306b\u809d\u81d3\u306e\u3053\u308c\u3089\u306e\u53d7\u5bb9\u4f53\u3068\u306e\u76f8\u4e92\u4f5c\u7528\u3092\u901a\u3058\u3066\u3001\u809d\u8102\u80aa\u306e\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3001\u4ee3\u8b1d\u6307\u6a19\u3092\u6539\u5584\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u3001MASH\u306e\u6f5c\u5728\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u306a\u308a\u5f97\u307e\u3059\u3002 \u300cALG-055009\u300d\u306f\u3001MASH\u306e\u7ba1\u7406\u3092\u76ee\u7684\u3068\u3057\u305f\u30af\u30e9\u30b9\u6700\u9ad8\u306e\u7532\u72b6\u817a\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u30d9\u30fc\u30bf\u4f5c\u52d5\u85ac\u3067\u3059\u3002\u8102\u8cea\u4ee3\u8b1d\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u30bf\u30f3\u30d1\u30af\u8cea\u3067\u3042\u308bAPOC3\u306e\u963b\u5bb3\u3092\u901a\u3058\u3066\u305d\u306e\u52b9\u679c\u3092\u767a\u63ee\u3057\u307e\u3059\u3002ALG-055009\u306b\u3088\u308bAPOC3\u306e\u963b\u5bb3\u306f\u3001\u6b63\u5e38\u306a\u8102\u8cea\u4ee3\u8b1d\u3092\u56de\u5fa9\u3055\u305b\u3001\u809d\u8102\u80aa\u84c4\u7a4d\u3092\u6e1b\u5c11\u3055\u305b\u3066\u30a4\u30f3\u30b9\u30ea\u30f3\u611f\u53d7\u6027\u3092\u9ad8\u3081\u3001\u305d\u308c\u306b\u3088\u308a\u708e\u75c7\u3068\u7dda\u7dad\u5316\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u307e\u3059\u3002 \u672c\u7814\u7a76\u306e\u5bfe\u8c61\u671f\u9593\u306f\u3001\u57fa\u6e96\u5e74\u304c2024\u5e74\u3001\u904e\u53bb\u671f\u9593\u304c2019\u5e74\u304b\u30892024\u5e74\u3001\u5e02\u5834\u4e88\u6e2c\u671f\u9593\u304c2025\u5e74\u304b\u30892035\u5e74\u3067\u3059\u3002\u5bfe\u8c61\u56fd\u306f\u7c73\u56fd\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u65e5\u672c\u304c\u542b\u307e\u308c\u3001\u5404\u56fd\u306b\u304a\u3051\u308b\u904e\u53bb\u3001\u73fe\u5728\u3001\u304a\u3088\u3073\u4e88\u6e2c\u5206\u6790\u304c\u30ab\u30d0\u30fc\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u904e\u53bb\u3001\u73fe\u5728\u3001\u305d\u3057\u3066\u5c06\u6765\u306b\u308f\u305f\u308b\u5e02\u5834\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u3001\u75ab\u5b66\u30b7\u30ca\u30ea\u30aa\u3001\u304a\u3088\u3073\u69d8\u3005\u306a\u6cbb\u7642\u30ab\u30c6\u30b4\u30ea\u30fc\u306e\u52d5\u5411\u3092\u8a73\u7d30\u306b\u8a55\u4fa1\u3057\u307e\u3059\u3002 \u75ab\u5b66\u306e\u5074\u9762\u3067\u306f\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308bMASH\u306e\u6709\u75c5\u8005\u6570\uff082019-2035\u5e74\uff09\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u60a3\u8005\u30d7\u30fc\u30eb\u3092\u3001\u5e74\u9f62\u5225\u3001\u6027\u5225\u3092\u542b\u3080\u8a73\u7d30\u306a\u30c7\u30fc\u30bf\u3067\u5206\u6790\u3057\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u30012019\u5e74\u304b\u30892035\u5e74\u307e\u3067\u306e\u6709\u75c5\u8005\u6570\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u305d\u3057\u30662019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u60a3\u8005\u30d7\u30fc\u30eb\u898f\u6a21\u30682025\u5e74\u304b\u30892035\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u60a3\u8005\u30d7\u30fc\u30eb\u304c\u63d0\u793a\u3055\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u75ab\u5b66\u7684\u50be\u5411\u3092\u63a8\u9032\u3059\u308b\u4e3b\u8981\u56e0\u3068\u60a3\u8005\u6570\u306e\u6210\u9577\u7387\u3082\u4e88\u6e2c\u3057\u3001MASH\u306e\u75be\u60a3\u8ca0\u62c5\u306b\u95a2\u3059\u308b\u6df1\u3044\u6d1e\u5bdf\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002 \u5e02\u5834\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306b\u3064\u3044\u3066\u306f\u3001MASH\u5e02\u5834\u5168\u4f53\u306e\u904e\u53bb\u3001\u73fe\u5728\u3001\u5c06\u6765\u306e\u52d5\u5411\u3092\u8a55\u4fa1\u3057\u3001\u69d8\u3005\u306a\u6cbb\u7642\u30ab\u30c6\u30b4\u30ea\u30fc\u306e\u5e02\u5834\u30b7\u30a7\u30a2\uff082024\u5e74\u304a\u3088\u30732035\u5e74\u4e88\u6e2c\uff09\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308b\u5404\u56fd\u5225\u306eMASH\u5e02\u5834\u898f\u6a21\uff082024\u5e74\u304a\u3088\u30732035\u5e74\u4e88\u6e2c\uff09\u3001\u5e02\u5834\u306e\u6210\u9577\u7387\u3001\u305d\u3057\u3066\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3092\u660e\u3089\u304b\u306b\u3057\u307e\u3059\u3002\u69d8\u3005\u306a\u85ac\u5264\u306e\u58f2\u4e0a\u9ad8\u3084\u511f\u9084\u30b7\u30ca\u30ea\u30aa\u3082\u8a73\u7d30\u306b\u5206\u6790\u5bfe\u8c61\u3068\u306a\u308a\u307e\u3059\u3002 \u6cbb\u7642\u85ac\u306e\u72b6\u6cc1\u3068\u3057\u3066\u3001\u73fe\u5728\u5e02\u8ca9\u3055\u308c\u3066\u3044\u308b\u85ac\u5264\u3068\u5f8c\u671f\u6bb5\u968e\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u5264\u306e\u4e21\u65b9\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u3001\u5404\u85ac\u5264\u306e\u6982\u8981\u3001\u4f5c\u7528\u6a5f\u5e8f\u3001\u898f\u5236\u72b6\u6cc1\u3001\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3001\u85ac\u5264\u306e\u666e\u53ca\u72b6\u6cc1\u3001\u5e02\u5834\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u5177\u4f53\u7684\u306b\u306f\u3001Madrigal Pharmaceuticals\u306eRezdiffra\uff08Resmetirom\uff09\u300189bio\u306ePegozafermin\u3001Akero Therapeutics\u306eEfruxifermin\u3001Corcept Therapeutics\u306eMiricorilant\u3001Aligos Therapeutics\u306eALG-055009\u3001Regeneron Pharmaceuticals\u306eALN-HSD\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u3053\u308c\u3089\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3082\u8a55\u4fa1\u3055\u308c\u307e\u3059\u3002\u73fe\u5728\u306e\u6cbb\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3082\u4e3b\u89817\u5e02\u5834\u5168\u4f53\u3067\u691c\u8a0e\u3055\u308c\u307e\u3059\u3002 \u7af6\u4e89\u74b0\u5883\u306b\u3064\u3044\u3066\u306f\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u4e3b\u8981\u4f01\u696d\u306e\u7279\u5b9a\u3068\u305d\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3001MASH\u5e02\u5834\u306b\u95a2\u9023\u3059\u308b\u4e3b\u8981\u306a\u5408\u4f75\u30fb\u8cb7\u53ce\uff08M&A\uff09\u3001\u30e9\u30a4\u30bb\u30f3\u30b9\u6d3b\u52d5\u3001\u63d0\u643a\u306a\u3069\u306e\u91cd\u8981\u306a\u4f01\u696d\u6d3b\u52d5\u3001\u304a\u3088\u3073\u4e3b\u8981\u306a\u898f\u5236\u30a4\u30d9\u30f3\u30c8\u3092\u7db2\u7f85\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u5e02\u5834\u306e\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3068\u4e3b\u8981\u30d7\u30ec\u30a4\u30e4\u30fc\u306e\u6226\u7565\u7684\u52d5\u304d\u304c\u660e\u78ba\u306b\u306a\u308a\u307e\u3059\u3002 \u3055\u3089\u306b\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u72b6\u6cc1\u3082\u3001\u305d\u306e\u30b9\u30c6\u30fc\u30bf\u30b9\u3001\u30d5\u30a7\u30fc\u30ba\u3001\u6295\u4e0e\u7d4c\u8def\u5225\u306b\u69cb\u9020\u3092\u5206\u6790\u3057\u3001MASH\u6cbb\u7642\u85ac\u958b\u767a\u306e\u73fe\u72b6\u3068\u5c06\u6765\u306e\u65b9\u5411\u6027\u3092\u6df1\u304f\u6398\u308a\u4e0b\u3052\u307e\u3059\u3002 \u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001MASH\u5e02\u5834\u304c\u3053\u308c\u307e\u3067\u3069\u306e\u3088\u3046\u306b\u63a8\u79fb\u3057\u3001\u4eca\u5f8c\u6570\u5e74\u9593\u3067\u3069\u306e\u3088\u3046\u306b\u5909\u5316\u3059\u308b\u304b\u30012024\u5e74\u306b\u304a\u3051\u308b\u69d8\u3005\u306a\u6cbb\u7642\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u30682035\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u3001\u4e3b\u89817\u5e02\u5834\u306b\u304a\u3051\u308bMASH\u5e02\u5834\u306e\u56fd\u5225\u898f\u6a21\u3068\u6210\u9577\u7387\u3001\u305d\u3057\u3066\u5e02\u5834\u306e\u4e3b\u8981\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3068\u3044\u3063\u305f\u3001\u91cd\u8981\u306a\u5e02\u5834\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u307e\u305f\u3001MASH\u306e\u6709\u75c5\u8005\u6570\u3001\u8a3a\u65ad\u60a3\u8005\u6570\u3001\u60a3\u8005\u30d7\u30fc\u30eb\u306e\u4e88\u6e2c\u3001\u75ab\u5b66\u7684\u50be\u5411\u3092\u63a8\u9032\u3059\u308b\u4e3b\u8981\u56e0\u3001\u60a3\u8005\u6570\u306e\u6210\u9577\u7387\u3068\u3044\u3063\u305f\u75ab\u5b66\u30a4\u30f3\u30b5\u30a4\u30c8\u3082\u63d0\u4f9b\u3057\u307e\u3059\u3002\u73fe\u5728\u306e\u5e02\u8ca9\u85ac\u3068\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u85ac\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3001MASH\u5e02\u5834\u306b\u95a2\u9023\u3059\u308b\u4e3b\u8981\u306a\u4f01\u696d\u6d3b\u52d5\u3084\u898f\u5236\u30a4\u30d9\u30f3\u30c8\u306b\u95a2\u3059\u308b\u60c5\u5831\u3082\u7db2\u7f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u3053\u306e\u5305\u62ec\u7684\u306a\u5206\u6790\u306b\u3088\u308a\u3001MASH\u5e02\u5834\u306e\u9032\u5316\u3059\u308b\u72b6\u6cc1\u3001\u6cbb\u7642\u306e\u9032\u6b69\u3001\u304a\u3088\u3073\u5c06\u6765\u306e\u6a5f\u4f1a\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u6d1e\u5bdf\u304c\u5f97\u3089\u308c\u3001\u95a2\u4fc2\u8005\u304c\u60c5\u5831\u306b\u57fa\u3065\u3044\u305f\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u305f\u3081\u306e\u5f37\u56fa\u306a\u57fa\u76e4\u3068\u306a\u308a\u307e\u3059\u3002","og_url":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/","og_site_name":"GlobalResearch.jp","article_published_time":"2026-02-14T15:30:24+00:00","article_modified_time":"2026-02-24T02:09:38+00:00","og_image":[{"url":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp"}],"author":"globalresearch","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"globalresearch","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/","url":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/","name":"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74","isPartOf":{"@id":"https:\/\/www.marketreport.jp\/insight\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#primaryimage"},"image":{"@id":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp","datePublished":"2026-02-14T15:30:24+00:00","dateModified":"2026-02-24T02:09:38+00:00","author":{"@id":"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4"},"breadcrumb":{"@id":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#primaryimage","url":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp","contentUrl":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/0737449d-ed4c-42f9-ab13-278f078f2ec7pharma9.webp","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.globalresearch.jp\/data\/metabolic-dysfunction-associated-steatohepatitis-market-imarc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.globalresearch.jp\/data\/"},{"@type":"ListItem","position":2,"name":"\u4e16\u754c\u306e\u4ee3\u8b1d\u6a5f\u80fd\u969c\u5bb3\u95a2\u9023\u8102\u80aa\u809d\u708e\u5e02\u5834\u898f\u6a21\u3001\u75ab\u5b66\u3001\u4e0a\u5e02\u85ac\u58f2\u4e0a\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u6cbb\u7642\u85ac\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u5c55\u671b 2025\u5e74\uff5e2035\u5e74"}]},{"@type":"WebSite","@id":"https:\/\/www.marketreport.jp\/insight\/#website","url":"https:\/\/www.marketreport.jp\/insight\/","name":"GlobalResearch.jp","description":"\u2756\u30b0\u30ed\u30fc\u30d0\u30eb\u8abf\u67fb\u30ec\u30dd\u30fc\u30c8\u8ca9\u58f2\u30b5\u30a4\u30c8\u2756","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketreport.jp\/insight\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4","name":"globalresearch","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g","caption":"globalresearch"},"sameAs":["https:\/\/www.marketreport.jp\/insight"],"url":"https:\/\/www.globalresearch.jp\/data\/author\/globalresearch\/"}]}},"_links":{"self":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/posts\/69505"}],"collection":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/comments?post=69505"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/posts\/69505\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/media?parent=69505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/categories?post=69505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/tags?post=69505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}